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The success of human pluripotent stem cells (hPSCs) as a source of future cell therapies 
hinges in part on the availability of a robust scalable culture system that can readily produce 
clinically relevant number of cells and their derivatives. Stirred suspension culture has been 
identified as one of such promising platforms due to its ease of use, scalability, and 
widespread use in the pharmaceutical industry (e.g., CHO cell-based production of 
therapeutic proteins) among others. However, culture of undifferentiated hPSCs in stirred 
suspension is a relatively new development in the past several years, and little is known 
beyond empirically optimized culture parameters. The goal of this study was to elucidate 
the impact of fluidic agitation on hPSCs in stirred suspension culture. In particular, we 
systematically investigated various agitation rates to characterize their impact on cell yield, 
viability, and maintenance of pluripotency. Additionally, we closely examined the 
 viii 
distribution of cell aggregates and how the observed culture outcomes are attributed to their 
size distribution. Our results showed that moderate agitation maximized the propagation of 
hPSCs by controlling the cell aggregates below the critical size, beyond which the cells 
suffer from diffusion limitation, while limiting cell death caused by excessive fluidic 
forces. Furthermore, we observed that fluidic agitation could regulate not only cell 
aggregation, but also expression of some key signaling proteins in hPSCs. Upon 
discovering this mechanosensitive effector enabled a novel approach for linking expansion 
and cardiac differentiation to generate over 90% cardiomyocytes. In addition, these 
cardiomyocytes displayed highly organized sarcomere structure which suggests an 
improved maturation in their morphology. Altogether, results presented in this study 
indicate the new possibility of guiding stem cell fate determination by fluidic agitation in 
stirred suspension cultures. 
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CHAPTER 1: 
INTRODUCTION 
 Recent development in human pluripotent stem cells (hPSCs) culture, including 
embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), has the potential 
to revolutionize the fields of tissue engineering and regenerative medicine. The importance 
of hPSCs lies in their capability to self-renew indefinitely while retaining their pluripotent 
capacity to form into any derivatives from all three germ layers: ectoderm, mesoderm, and 
endoderm [1-3]. This unique characteristic is the reason why many regard these cells to be 
the most versatile and promising renewable cell source for cell-based therapy, disease 
modeling, and drug discovery and screening (Figure 1.1) [4-6]. However, bringing their 
promising potential closer to clinical relevance is met with many challenges. At the 
forefront of these challenges is the strategy to deliver a clinically relevant quantity of 
hPSC-derivatives [7]. The issue is partly due to the lack of a robust, scalable and cost-
effective culture system that could readily meet the demands of anticipated clinical 
applications [8].  
For clinical applications, providing a particular number of high-quality cells is of 
utmost importance. The number of cells needed depends on the specific application, which 
can range from 105 to 109 specialized cells [8, 9]. For cell-based therapy, treatment to target 
diseases such as myocardial infarction, type I diabetes, and hepatic failure, would require 
transplantation of approximately 109 cardiomyocytes [9], insulin-producing β-cells [10], 
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and hepatocytes [11], respectively. Treatments for Parkinson’s disease, Stargardt’s macular 
dystrophy, and age-related macular degeneration will require at least 105 cells [12, 13]. The 
simplest strategy to produce such large number of specialized cells is first to exploit the 
self-renewal capacity of hPSCs and expand the undifferentiated population to such a high 
degree before differentiation towards a functional derivative. However, given the relatively 
low efficiency and cell yield of in vitro differentiation, not to mention in vivo survival of 
transplanted cells, supplying high-quality hPSC-derivatives on the order of 108 – 1010 could 
be necessary to satisfy the requirements of many cell-based therapies [14]. Consequently, 
expanding and maintaining undifferentiated hPSC culture would require a culture platform 
with greater scalability and reproducibility.  
To date, 2D monolayer culture systems are the gold standard and most widely used 
method for the expansion of hPSCs. However, this approach may not be ideal for the mass 
production of hPSCs and their derivatives. Nevertheless, it is through the discovery from 
2D monolayer cultures that have given researchers insight to controlling hPSCs’ fate and 
enabled an alternative solution for a more scalable culture platform in 3D suspension 
systems. As such, we will briefly discuss key developments in monolayer systems that have 
led to the discovery of a multifaceted network that controls hPSC culture outcomes. 
  
 3 
Development of hPSC Cultures in 2D Monolayer System 
Since the discovery of hESCs, 2D monolayer systems have been widely used to 
support the growth and pluripotent characteristics of these cells. Initially, the best condition 
for self-renewal and maintenance of pluripotency were on mouse embryonic fibroblasts 
(MEF) feeder layers (Figure 1.2Ai) [1]. However, the use of MEF feeder layers presents a 
risk for clinical applications because feeder-cells can be a source of pathogens for hPSCs. 
Therefore, the need for a feeder-free system has led to using specific extracellular matrix 
(ECM) to facilitate the attachment and growth of hPSCs. Matrigel is an animal-derived 
basement membrane matrix and was the first development of a feeder-free system that is 
still one of the most commonly used adherent substrates for hPSC cultures to date (Figure 
1.2Aii). Matrigel is comprised of various ECM proteins, proteoglycans, and undefined 
growth factors harvested from the Engelbreth–Holm–Swarm mouse sarcoma cells [15-17]. 
Unfortunately, similar to MEF feeder layers, Matrigel cannot be used for clinical 
applications due to safety concerns with xenogeneic components comprised in the 
substrate. As such, researchers have focused on developing a more defined xeno-free 
growth substrates from humanized protein mixture, peptide–polymer conjugate, 
recombinant protein, or polymeric substrates (Figure 1.2Aiii & 1.2Aiv) [18-22]. 
Nevertheless, such advances towards a feeder-free and xeno-free growth substrate would 
be impractical if the culture medium does not meet the same stringent requirement. For this 
reason, considerable efforts have also focused on developing a defined growth medium to 
truly eliminate xenogeneic elements for the ultimate goal of using hPSCs for biomedical 
purposes.  
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The growth medium is an essential component in hPSC culture. The first 
development of growth medium typically included fetal bovine serum (FBS) and MEF-
conditioned medium (MEF-CM), undefined secretory growth factors from MEF-feeder 
cells [17, 23]. In the past decade, researchers have identified key growth factors such as 
Activin A, Nodal, and FGF-2, to support the propagation of undifferentiated hESCs and 
establish a better-defined culture medium [24, 25]. The most significant development for 
a more defined culture medium was in 2006, when Thomson and colleagues developed the 
most widely published and recognized feeder-free growth medium, mTeSR1 [26, 27]. The 
formulation of mTeSR1 is a complex combination of soluble factors and chemical signals 
to support the continuous expansion and long-term maintenance of hPSCs (Figure 1.2B). 
Although not completely free of xenogeneic elements, mTeSR1 is a powerful growth 
medium that has been successfully demonstrated to support hundreds of hPSC lines in 
many different parts of the world. More recently, Thomson and colleagues further 
improved their chemically defined growth medium by developing the Essential 8 (E8) 
medium, which is a derivative of the mTeSR1 but contained only the essential eight 
components without the addition of both serum albumin and β-mercaptoethanol [28, 29]. 
The development of this growth medium has become the gold standard to support hPSCs 
maintenance in various culture platforms.  
Besides the ECM and soluble factors, the cellular microenvironment is also an 
important component that is worth consideration in hPSC cultures. In 2D monolayer 
cultures, it was found that environmental cues such as the physiological environment and 
physical forces could also influence hPSC fate decision for apoptosis, self-renewal or 
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differentiation. For instance, hPSCs are typically cultured under standard normoxic 
conditions (37°C, pH of 7.4, and 20% oxygen tension). But a study suggests that hPSC 
culture performs much better in an environment that recapitulates embryonic development 
such as low oxygen tension (hypoxia, 2-6% oxygen). The study reports that hPSCs self-
renewal was enhanced while the likelihood of spontaneous differentiation and 
chromosomal abnormalities decreased in long-term cultures [30]. Similarly, numerous 
reports have also indicated that physical cues and stimulation, which mimic early 
developmental stages, are known to be a critical factor for hPSC fate determination [31]. 
For instance, physical cues such as fluid shear or tensile and compressive strain via surface 
modification could have a significant impact on hPSC culture outcome (Figure 1.2C) [32-
34]. We will discuss more on how such forces influence stem cell physiology and 
molecular mechanisms in chapter 2. Nevertheless, these environmental factors have been 
extensively studied in 2D monolayer cultures, and these studies have provided great insight 
into regulating hPSCs’ behavior in vitro.   
Monolayer-based strategies have given researchers a foundation to control the stem 
cell’s unique properties to yield a promising product for clinical benefits. However, there 
are still many challenges ahead in bridging the gap between research discoveries and 
therapeutic applications. For instance, improving differentiation efficiency for the desired 
cell type, maintaining long-term genetic stability, ensuring higher purity of clinical grade 
cells, and attaining scalability for mass production are some issues that need to be resolved 
before widespread clinical use. Fortunately, research in these aspects is in full swing, but 
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the limited scalability of 2D monolayer cultures is one major challenge that may not be 
addressed easily.  
Limitation of 2D Monolayer Cultures for Scalable hPSC Bioprocesses 
Monolayer cultures of hPSC have evolved quickly over the last decade to a point 
where many protocols have been established for the propagation and direct differentiation 
of hPSCs to a variety of cell lineages such as, but not limited to, hPSC-derived 
cardiomyocytes, pancreatic β-cells, hepatocytes and motor neurons. A number of these 
established protocols still depend on monolayer-based strategies for cell expansion and 
differentiation, but for scaling up to produce large numbers of specialized quality cells, 
monolayer-based strategies themselves could be the limiting factor for a more rapid 
implementation of hPSC-derived products [35]. Monolayer-based systems are known for 
its lack of scalability because the process to produce large cell number is achieved by 
increasing the 2D surface area for growth. Therefore, for hPSC cultures, surface 
enlargement also require an increase in candidate growth substrate as well as culture flask 
to accommodate the attachment and propagation of hPSCs without compromising their 
pluripotent characteristics [36]. Consequently, processing of many culture flasks in order 
generate large cell number would be time-consuming, labor intensive and an expensive 
process (Figure 1.3) [37]. Not to mention that the candidate growth substrate should be 
defined, xenogeneic-free, and serum-free for safer use in clinical applications [36]. 
Although such substrates have been commercially developed for safer use in clinical 
applications, Celiz et al. report that the cost of using these candidate substrates to produce 
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1 billion hPSCs alone is expensive (Table 1.1) [38]. In addition, despite considerable 
efforts in developing an inexpensive polymer substrate to reduce material cost, synthetic 
growth substrates still have significant limitations in production and cost for scalable 
manufacturing process [38]. These limitations present a bottleneck for 2D monolayer 
cultures to succeed as a real working platform for clinical-scale productions.  
3D Suspension Cultures Enable Scalable Production of hPSCs 
Alternatively, 3D suspension cultures provide a more promising scalable platform 
for the mass production of hPSCs than 2D monolayer-based systems [35]. What makes 
suspension methods more suitable for large-scale production is that 3D systems are not 
restricted to a 2D surface area to accommodate the propagation of cells [36]. Therefore, 
production of hPSCs could be scaled-up in volume with relative ease, as opposed to scaling 
out to multiple culture flasks [37]. Also, discoveries from 2D monolayer systems have 
benefited greatly for 3D suspension cultures, such as the use of growth medium and ECM 
substrates to support self-renewal and maintenance of pluripotency of hPSCs in 
suspension. Over the past decade, a variety of 3D suspension culture methods have been 
successfully established to facilitate the survival of cells in suspension: Cells immobilized 
on microcarriers [39-41], microencapsulation of cells [42-44], or self-aggregated hPSCs 
spheroids (Figure 1.4A) [45-47]. Also, these methods could be cultured under static 
suspension or various forms of dynamic suspension cultures including rotary orbital 
shakers, slow-turning lateral vessels (STLV), or spinner flask/tank bioreactors to name a 
few (Figure 1.4B). There is no standard approach to culturing hPSCs in 3D suspension 
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because every method has its benefits and pitfalls. Therefore, an understanding of the 
features in each culture method would provide us with some insight into its practical 
applications in generating large quantities of cells at a reasonable cost.  
Microcarriers are small spherical particles that facilitate attachment of anchorage-
dependent cells to be grown in suspension (Figure 1.4Ai). Although typically kept in 
suspension by stirring or other dynamic mechanisms, microcarriers enable a simple process 
to control cellular aggregation of hPSCs. The carriers enhance surface area attachment to 
volume ratio and allow options for different coating matrices or porous properties to 
improve hPSC expansion without compromising their differentiation potential [48, 49]. 
However, limitations of this approach are the material cost needed to optimize 
microcarriers with specific matrices and porous properties as well as additional labor for 
the cell-carrier separation process. Also, the shear stress experienced by the cells in 
dynamic microcarriers culture is a concern and will require additional studies to understand 
the cell’s response to the hydrodynamic environment and physical properties of the 
microcarrier.  
The development of microencapsulation technology enables a strategy to tightly 
control cell clump size and still provide a high surface-to-volume ratio for cell growth 
(Figure 1.4Aii). Microencapsulation also protects the cells from excessive shear force 
related damage in dynamic suspension systems and could facilitate an integrated strategy 
for expansion with cryopreservation of hPSCs [43]. One study has successfully 
demonstrated this integrated process and has reported a recovery rate greater than 70% 
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after cryopreservation [50]. The biomaterial to encapsulate the cells could also be 
engineered to improve culture performance as well as reproducibility. However, the 
physical properties of encapsulation allow limited flexibility to monitor the cell growth or 
characterize molecular diffusion inside the capsule. Notably, similar to microcarriers, the 
cost associated with the biomaterial and process to harvest the cells by decapsulation are 
some shortcomings of this method. 
Without the use of microcarriers or encapsulation, hPSCs could adhere together and 
form free-floating cell aggregate spheroids (Figure 1.4Aiii). This default aggregate 
formation is vital for the survival and growth of hPSCs in suspension. Typically, the 3D 
spherical structure comprised of hPSCs is known as embryoid bodies (EBs). In this 
discussion, we characterize EBs as cell aggregate spheroids undergoing spontaneous 
differentiation in suspension [51], whereas hPSCs aggregates are the 3D spherical structure 
where the cells maintain their undifferentiated and pluripotent state [45]. Culturing hPSCs 
as aggregates allow the cells to retain their high differentiation efficiency because the 3D 
cell-cell contact is preserved to sustain endogenous signaling within the cell aggregate [35]. 
In recent years, aggregate cultures have been successfully demonstrated to enable the long-
term expansion of hPSCs without the need of costly substrates and microcarriers to 
maintain their pluripotent characteristics in suspension [36]. However, controlling the 
aggregate size and preventing excessive agglomeration are common issues that could 
significantly affect the culture outcome [52]. To minimize agglomeration, hPSCs 
aggregates cultured in dynamic suspension systems have proved to be more effective in 
producing uniform aggregate size and improve cell production yield than static suspension 
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conditions [47]. Unfortunately, similar to microcarriers, the lack of knowledge in how the 
hydrodynamic shear force effects hPSC self-renewal or lineage determination is a concern 
that leads to many uncertainties in controlling the culture outcome.  
Although each method has its own benefits and shortcomings that need to be 
addressed, the high surface-to-volume ratio in 3D suspension cultures enables a scalable 
platform for meeting the ultimate goal of generating clinically relevant quantities of cells 
with relative ease. Ultimately, the development of a fully automated and controllable 
bioprocess systems will be required for the industrial scale-up production of cells. Stirred 
tank bioreactors have been the standard for chemical engineering and bioprocessing 
industries because of the numerous flexibility to fully automate, monitor and control 
specific culture parameters. Also, using the hPSCs aggregate approach, and integrating the 
process for expansion with differentiation in stirred suspension culture would be the 
simplest, cost-effective and ideal method for the scalable production of hPSCs and their 
derivatives (Figure 1.5). However, in order for stirred-tank bioreactors to be considered as 
a viable alternative for stem cell bioprocessing, understanding the impact of hydrodynamic 
conditions on stem cell physiology is one major issue that needs to be addressed for future 
development.  
Benefits and Drawbacks of Aggregate Suspension Culture of hPSCs 
In the past few years, studies on hPSCs aggregates cultured in stirring vessels have 
shown great results in generating a large number of cells for future applications. In fact, 
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across various reports, stirred suspension cultures proved to be more effective in the 
expansion of undifferentiated hPSCs than static suspension conditions [36]. Static 
suspension culture is often subject to agglomeration, whereby individual aggregates clump 
together in a stochastic manner and form large clusters that result in an increase in growth 
rates variability, apoptosis, and heterogeneity [53-55]. On the other hand, spinner flasks 
and stirred-tank bioreactors apply agitation via impeller to induce fluid motion and assure 
sufficient mixing of chemicals and dissolved gasses in the culture media. Indeed, applying 
agitation was beneficial to minimize agglomeration and heterogeneous growth conditions, 
thereby promoting higher cell yield as previous reports indicate. The question now arising 
is how the hydrodynamic shear force imparted by fluid agitation affects hPSCs in regards 
to controlling the culture for survival, self-renewal, or directed differentiation in dynamic 
suspension systems.  
At present, there is a lack of consensus for the optimal growth conditions in stirred 
suspension protocols. For instance, the optimal agitation rate for the expansion of hPSCs 
often varies from one system to another [56, 57]. The main reason for this is due to the 
complexity of hydrodynamic motions present in different designs of the culture vessels. 
Therefore, tailoring protocols for specific purposes is difficult because the key parameters 
that control the culture outcome have not yet been fully understood [58]. Development of 
analytical technologies such as particle-image-velocimetry (PIV) measurements (Figure 
1.6A) and computational fluid dynamics (CFD) (Figure 1.6B) have at least provided a 
quantitative characterization on how the hydrodynamic forces, such as fluid shear, could 
affect the cells in dynamic suspension cultures [59, 60]. From these studies, it was found 
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that the magnitude of shear stress could spatially vary 10-100 times within the culture 
vessel. Also, internal fluid friction known as eddy viscosity (µT) can also have a significant 
impact on the local shear stress the cells experienced in culture [61]. Thus, drawing 
comparisons from separate studies to establish a standard optimal protocol presents a 
challenge in itself because the complexity of hydrodynamic forces depends on the specific 
culture parameters (e.g. medium properties, agitation rates, and inoculation density) and 
the design of the vessel.  
How hPSCs respond to the hydrodynamic environment is another key topic that 
requires more investigation. Specifically, knowledge of how the mixing conditions impact 
cells’ survival, aggregation, and phenotype with respect to their signaling mechanisms will 
be extremely beneficial for a more standard approach to controlling the culture outcome of 
hPSCs in stirred suspension systems. Clearly, viability will depend on the thresholds of 
shear stress that the cells can tolerate. However, the aggregate size is also known to have 
an effect on the cells viability and phenotype. As such, there should be a fine balance 
between the mixing condition that is necessary for aggregation and to produce uniformed 
sized aggregates of a particular size while limiting excessive force-related cell death. More 
importantly, understanding of core signaling pathways and how they are influenced by 
suspension cultures is important for the control of hPSCs fate in stirred suspension systems 
(Figure 1.6C). Insight into signaling pathways that are modulated by fluidic agitation will 
provide huge implications to tailoring protocols for specific purposes. Altogether, it is 
expected that such knowledge will enable a more standardized process to controlling the 
culture outcome of hPSCs in stirred suspension systems.  
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Objective and Significance 
Our long-term goal is to develop a scalable manufacturing culture system that can 
produce a clinically relevant number of hPSCs and its derivatives for clinical applications. 
For this reason, we explore how the dynamic fluid microenvironment impacts cellular 
responses manifested by the propagation, viability, aggregation and phenotype of hPSCs 
in stirred suspension cultures. Since these responses are inter-related and attributed by 
multiple parameters – such as medium properties, agitation rates, and inoculation density 
– we use the optimal growth medium for the propagation of hPSCs in suspension and focus 
on investigating the impact of different agitation rates on cellular responses of hPSCs. In 
addition, cellular responses of hPSCs are dictated by their signaling pathways, so we also 
evaluate possible molecular mechanisms that are modulated due to fluidic agitation. Our 
principle hypothesis is that hPSCs are sensitive to stirring-induced shear force, thereby 
altering signaling mechanisms to promote survival, self-renewal or differentiation. The 
basis of our hypothesis is from our literature study of micromechanical cues affecting hPSC 
regulation and fate (Chapter 2), and our preliminary data using a conventional spinner flask 
to assess the impact of fluidic agitation on hPSCs (Chapter 3). The rationale for the research 
is that, once candidate mechanosensitive signaling proteins governed by fluid agitation are 
identified, they can be leveraged to steer cell fate decisions along with or in place of 
chemical cues. Altogether, by gaining some insight into both cellular responses and 
molecular mechanism, we report the effective parameters to enhance the scalable 
production and differentiation of hPSCs in stirred suspension culture.  
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Table & Figures 
I Table 1.1. Development of defined growth substrates for hPSC expansion in 2D 
monolayer cultures. Growth substrate, culture medium, and price of scalability are given 
to get an estimated total cost of producing 1 billion hPSCs. The estimated cost is based on 
(a & b) using 100 coated T75 flasks, (c) 150 kits to coat a sufficient number of 6-well 
plates, and (d) considering it to be equal to or more expensive than similar recombinant 
protein-based substrate such as StemAdhere. Adapted from Celiz et al., 2014 [38].   
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Matrigel mTeSR1 $15 per T75 (a) ~$1,500    
Synthemax 
(peptide-polymer 
conjugate) 
X-VIVO 10,  
80 ng/ml hrbFGF, 
0.5 ng/ml hrTGF-β 
$380 per 10 mg 
$80 per 6-well plate 
$100 per T75 
$295 per T225 
(b) ~$10,000 x x x 
StemAdhere 
(recombinant  
E-cadherin) 
mTeSR1 
$100 per kit 
$22 per 0.5 mg 
(c) ~$15,000 x x x 
Peptide-SAM 
(synthetic 
peptide) 
mTeSR1 + ROCKi Expensive (d) >$15,000 x x x 
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Figure 1.1. Overview of human pluripotent stem cells (hPSCs) bioprocess for clinical 
applications. Self-renewal capacity of hPSCs are first exploited for expansion to large 
numbers, followed by differentiation into specific functional derivatives, and lastly, 
clinical applications for cell-based therapy, disease modeling, and drug screening [63].   
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Figure 1.2. Development of 2D monolayer cultures of hPSCs. (A) The progress of growth 
substrates from (i) MEF feeder layers to (ii) Matrigel, (iii) Protein/peptide-based, and (iv) 
Polymer-based growth substrates. (B) Enacting soluble factors and chemical cues in culture 
media have paved the way to control hPSCs fate for optimal growth and differentiation. 
(C) Other cues such as mechanical stimulation in the microenvironment were also found 
to affect stem cell fate in 2D cultures.     
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Figure 1.3. 2D process strategy to produce 1 billion hPSCs requires multiple culture flask 
coated with growth substrates and labor-intensive uptake and handling.  
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Figure 1.4. 3D suspension cultures enable the easily scalable production of hPSCs. (A) 
hPSCs could be cultured in suspension by i) microcarriers, ii) microencapsulation, or iii) 
as cell aggregates. Adapted from Serra et al., 2012 [35]. (B) These methods could also be 
cultured in various dynamic suspension platforms such as Rotary orbital shakers [62], slow 
turning lateral vessels [62], and spinner flask bioreactor.   
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Figure 1.5. Overview of hPSC bioprocess strategy in 3D dynamic suspension culture vs. 
2D monolayer based methods. (A) Transitioning from a monolayer to aggregate suspension 
culture using a spinner flask does not require costly substrates for growth. (B) Expanding 
hPSCs in suspension requires (C) scaling up in volume with relative ease. (D) Integrated 
process for hPSC expansion and differentiation will be extremely useful to (E) store and 
readily provide a large number of desired cell type for transplantation.   
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Figure 1.6. (A) PIV overview. Laser source and a cylindrical lens are used to create a thin 
illuminated image plane as the camera captures sequential images of moving particles in 
the fluid. (B) CFD could illustrate the flow characteristics and shear stress distribution at 
varying agitation rates. (C) Uncovering potential signaling pathways that are modulated by 
fluid shear in 3D dynamic suspension cultures.   
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CHAPTER 2: 
ENGINEERED MICROMECHANICAL CUES AFFECTING HUMAN 
PLURIPOTENT STEM CELL REGULATIONS AND FATE  
Abstract 
The survival, growth, self-renewal, and differentiation of human pluripotent stem cells 
(hPSCs) are influenced by their microenvironment, or so-called “niche,” consisting of 
particular chemical and physical cues. Previous studies on mesenchymal stem cells and 
other stem cells have collectively uncovered the importance of physical cues and have 
begun to shed light on how stem cells sense and process such cues. In an attempt to support 
similar progress in mechanobiology of hPSCs, we review mechanosensory machinery, 
which plays an important role in cell–extracellular matrix interactions, cell-cell 
interactions, and subsequent intracellular responses. In addition, we review recent studies 
on the mechanobiology of hPSCs, in which engineered micromechanical environments 
were used to investigate effects of specific physical cues. Identifying key physical cues and 
understanding their mechanism will ultimately help in harnessing the full potential of 
hPSCs for clinical applications. 
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Introduction 
For every cell type, its microenvironment, consisting of chemical cues and physical 
cues, is essential for regulating and maintaining cellular functions and fate [1-4]. Although 
early studies suggest chemical cues, such as growth factors, cytokines, hormones, and 
extracellular matrix (ECM) ligands, are the major factors that regulate cellular activity [5-
8], recent studies on a wide range of cell types collectively indicate the importance of 
physical cues, such as intercellular forces, matrix mechanical properties, and surface 
topography, to further influence cellular regulation [9-11]. These factors are most evident 
particularly, during embryogenesis and organogenesis, where chemical cues deliver a 
direct signal to stem cells and progenitors via paracrine, autocrine, or endocrine signaling 
for an intracellular command, and physical cues set the stage for morphogenesis and guide 
the process during development [12-14]. Observation and identification of such factors and 
their spatiotemporal changes led to a number of effective protocols for maintenance and 
differentiation of stem cells in vitro [15, 16]. Human pluripotent stem cells (hPSCs), 
including embryonic stem cells (hESCs) [17] and induced pluripotent stem cells (hiPSCs) 
[18, 19], are no exception, although these artificially established cell lines do not exist 
naturally in an adult body. 
Over the past 15 years, hPSC culture has advanced significantly thanks to 
identification of essential growth factors and specific substrate coatings that allow for 
cellular growth, survival, and maintenance of the undifferentiated state [20-22]. For 
instance, adherent substrate coatings, such as Matrigel, purified ECM proteins, and even 
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fully synthetic polymers, in combination with a chemically defined growth medium, such 
as mTeSR, can now sustain long-term maintenance of hPSC under serum- and feeder-free 
condition [20, 23-25]. Such chemically defined culture systems further enabled discovery 
of a vast array of imperative regulations and signaling cues of stem cells. For example, 
specific growth factors in the transforming growth factor–β (TGF-b)  superfamily, basic 
fibroblast growth factor, and insulin-like growth factors are essential for hESC 
maintenance, survival, and proliferation (reviewed extensively by Avery et al. [26] and 
Oshimori and Fuchs [27]). In addition, control of stem cell fate by specific inhibition of 
certain kinases such as the glycogen synthase kinase (GSK), mitogen-activated protein 
kinase (MAPK), and Rho-associated protein kinase (ROCK) has been demonstrated 
recently [28, 29].  On the other hand, understanding physical cues influencing hPSC 
regulations has been left behind until very recently. In one notable example, when 
subjected to cyclic biaxial mechanical strain, the TGF-β/Activin/Nodal pathways were 
activated and effectively inhibited differentiation of hESCs even without cytokines TGF-
β1 and Activin A, suggesting that mechanical cues are capable of regulating certain 
pathways [30, 31]. Clearly, detailed knowledge of the chemical and physical factors, as 
well as their synergistic effects, is necessary to emulate the complexity of the in vivo niche 
that controls cell transformation during the embryological process [32, 33].  
Recent advances in micro- and nano-fabrication technology and materials science 
has made engineered tools and platforms available for investigating effects of 
micromechanical cues on stem cell regulations. For example, specialized biomaterials have 
been used in hPSC cultures to mimic ECM properties of live tissue models [34-36]. 
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Furthermore, effects of physical cues such as matrix stiffness, surface texture, and surface 
topography on hPSCs and adult stem cells have been explored [37-41]. These studies have 
successfully observed how stem cells responded to these cues and started shedding light 
on pathways that dictate their fate for survival, self-renewal, and lineage commitment [33, 
42]. It is now evident that stem cells are capable of detecting various physical aspects of 
their microenvironment and translate such cues into intracellular biochemical signals that 
modulate cellular activity [43, 44]. Nevertheless, the complete mechanisms governing so-
called mechanotransduction of hPSCs by physical cues are far from being understood. In 
this review, to continue this progress, we will first summarize how stem cells, in general, 
can sense different physical cues in their environment by referring to previous 
mechanobiology studies. Interpreting results obtained from different cell types, particularly 
human mesenchymal stem cells (hMSCs), can segue into understanding hPSC regulations 
in engineered micromechanical environments. We will then survey recent studies that have 
begun to show the effects of engineered microenvironments in determining the fate of 
hPSCs for survival, self-renewal, or differentiation. Finally, we will conclude by offering 
what we envision in the future progress of this emerging field. 
Mechanosensory Machinery and Force Transmitter 
The distinction between chemical cues and physical cues is how stem cells detect 
them and process the information subsequently [44, 45]. Extrinsic chemical cues are 
detected by binding to and activating specific membrane protein receptors, which then 
transmit internal signals to activate (or inactivate) protein activators and co-activators for 
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gene regulation. On the other hand, specific mechanisms by which stem cells sense 
physical cues, particularly mechanical stimuli, are not fully understood. However, 
accumulated evidence suggests that the peripheral transmembrane proteins, such as 
integrins and cadherins, and nonmuscle myosin II (NMMII) play an active role in detecting 
and responding to the physical changes of the microenvironment [46]. Integrins and 
cadherins function as the mechanosensory machinery and NMMII is a complex motor 
protein that binds to cytosol’s actin filaments to form the actomyosin cytoskeleton (Figure 
2.1). As a result, cellular activity for motility, morphogenesis, and gene transcription could 
be regulated in the process of adapting to their physical micromechanical environment. An 
excellent review of mechanotransduction machinery and transcriptional regulators of both 
stem cells and non–stem cells was recently published by Mammoto et al. [47]. In our 
current article, because of limited space, we focus on the suspected major players including 
integrins, cadherins, and NMMII. 
Integrin: Cell-ECM Mechanical Sensor 
For every adherent cell, anchorage to the ECM is made by cell membrane–bound 
integrin-complex proteins at the focal adhesion site [48]. On the internal side of the 
membrane, the integrin proteins are also integrated with the actomyosin cytoskeleton 
(Figure 2.1) [49]. Therefore, the link between the cell membrane and the ECM goes far 
beyond the attachment site and is actually the start point of a communication network 
between the cell and microenvironment [50-52]. CellECM communication is vital for 
hPSC function and activity as it provides essential signals for maintenance of pluripotency, 
self-renewal, and survival [53]. However, little is known about mechanical cues induced 
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by the ECM that control stem cell regulation and fate [54, 55]. One certain thing is that the 
properties of the ECM and underlying substrates such as elasticity, porosity, and 
spatiotemporal geometry and topography are among the physical stimuli that a cell, in 
essence, can “feel” [56, 57]. When the integrin complex binds to the ECM, the cell tends 
to conform to its microenvironment by modulating its intracellular mechanics. For 
instance, when murine or human MSCs were attached to a rigid substrate, they generated 
more traction force and consequently increased their cytoskeletal tension, emulating the 
substrate’s rigidity [38]. Conversely, when murine ESCs were attached to a substrate 
whose stiffness was similar to its normal cytoplasmic value, it sustained survival, self-
renewal, and the undifferentiated state [58, 59]. It is speculated that integrin adjustment 
and clustering is responsible for the increase in traction force and subsequent cytoskeletal 
tension [60-63]. Nevertheless, many studies point to NMMII activity and the Rho/ROCK 
pathway as the major players that generate cytoskeletal tension. The Rho/ROCK pathway 
is a molecular feedback mechanism known to be associated with the mechanosensory 
machinery that regulates NMMII activity (see “NMMII: Mechanical Motor Modulating 
Cellular Function and Cytoskeleton”). Importantly, the formation of focal adhesion up-
regulates Rho/ROCK and consequently induces NMMII activity to increase traction force 
as well as cytoskeletal tension.  
Integrin-mediated adhesion pathways are vital for stem cell function and activity. 
For instance, researchers observed that an elevated activity of the Rho/ROCK pathway was 
consistent with hyperactivation of NMMII, followed by an instability and destruction of 
the cytoskeletal structure [64, 65]. This is now thought to be the main cause of dissociation-
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induced apoptosis of hESCs. As such, inhibition of the Rho/ ROCK pathway results in a 
higher percentage of hESC survival upon enzymatic dissociation into single cells [66]. 
Similarly, the phosphoinositide 3-kinase/Akt (PI3K/Akt) pathway and 
MAPK/extracellular-signal-regulated kinase (MAPK/ERK) pathway are the other integrin-
mediated adhesion pathways critical for cell survival and maintenance of pluripotency [67-
71]. Particularly, studies suggest that Akt negates apoptotic signals for sustaining 
continuous survival or delays the onset of cell death when single cell dissociation occurs 
[72, 73].  
However, identifying an exact molecular mechanism through which extrinsic 
forces command stem cell regulations has proven to be difficult due to cross-talk among 
many defined and undefined factors in the microenvironment. In an attempt to decouple 
mechanical factors, Huebsch et al. [74] engineered a substrate with defined mechanical 
properties and studied their effects on MSCs’ lineage commitment. By using a three-
dimensional (3D) hydrogel-based, synthetic ECM conjugated with integrin-binding RGD 
(Arg-GlyAsp)–modified ligands, they observed that differentiation correlated with the 
traction-dependent reorganization of integrins and the adhesive ligands in response to 
matrix elasticity and 3D architecture [74]. In addition, some have suggested that 
mechanical cues may cause tension-induced conformational changes of membrane proteins 
to expose sites that favor ligand interactions. For instance, Friedland et al. [75] showed that 
integrin-complex receptors could alter their affinity strength in response to cytoskeleton 
tension and stress. The same physical force may also present dormant growth factors in an 
active form when stress is involved [76]. In addition, there are numerous examples of ion 
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channels, membrane receptor proteins, and intracellular proteins being constantly regulated 
when mechanical forces are applied [77-80]. It is, however, still debatable how exactly 
mechanical stimuli influence changes in transcriptional regulation. Nevertheless, integrin-
ECM binding provides crucial inputs for chemical and physical signal transduction [81]. 
Cadherin: Cell-Cell Mechanical Sensor 
Similar to the integrins complex on the focal adhesion site, transmembrane 
glycoprotein cadherins in the adherens junction has also been shown to function as a sensor 
for many cellular activities [82]. Besides mediating cell-cell interactions via a cadherin-
cadherin bond as a form of communication among neighboring cells, the adherens junction 
is capable of detecting external forces in its peripheral surroundings, independent of the 
ECM [83]. Figuratively, the integrin complex acts as a foot to feel its platform, whereas 
the cadherin acts as a hand to sense its lateral microenvironment (Figure 2.1). This 
mechanism is essential for hESCs because organogenesis depends on cell-cell 
communication during the embryological process [84]. For instance, E-cadherin is highly 
expressed in undifferentiated hESCs, whereas an increase in expression of N-cadherin and 
VE-cadherin is required for neural formation and angiogenesis, respectively [85, 86].  
The adherens junction is also linked to the cytoskeletal architecture of the cell via 
cadherin binding to β-catenin in the cytoplasm (Figure 2.1). Therefore, when cadherin-
cadherin binding forms between two cells, the cytoskeletal backbone is also connected 
together. Consequently, each cell can affect the cytoskeletal tension of the other in the 
presence or absence of an external force. For example, Liu et al.[87] observed that the 
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adherens junctions between two endothelial cells changed in size and strength in response 
to cell-cell contact force under mechanical loading. Using a micromechanical force sensor, 
they measured traction force generated by the cells and quantified local contact force at the 
cell-cell adhesion site. This entails that the cadherin feedback mechanism is similar to that 
of integrins, where force-induced cellular functions are mediated by myosin activity [82]. 
It is important to note that even though Liu’s work was based on endothelial cells, integrin-
based adhesion, and cadherin-based adhesion are vital anchorage mechanisms that link to 
the actomyosin cytoskeleton in hPSCs. Consequently, both adhesion complexes may have 
the ability to mediate force-dependent regulation for survival, growth, morphology, and 
function of stem cells. Recent studies demonstrated that an excessive perturbation of cell-
cell contact in hESCs resulted in the collapse of the intracellular architecture, leading to 
cell blebbing and eventually dissociation-induced apoptosis [64, 65]. This process was 
likely mediated by the Rho/ROCK pathway and NMMII hyperactivation. 
Even though both the focal adhesion and adherens junction function as 
mechanosensory machinery, it is said their signaling mechanism can have different effects 
on hPSC fate and activity [71]. For instance, some reports suggest that the focal adhesion 
mechanism is necessary for cell migration and differentiation of hPSCs [88], whereas 
cadherin binding is necessary for colony formation, pluripotency maintenance, and long-
term survival. The cadherin-mediated regulation was evidenced in a study by Li et al. [89] 
on short-term and long-term inhibition of NMMII using blebbistatin, a NMMII ATPase 
inhibitor. Temporal inhibition of NMMII using blebbistatin increased single cell survival 
of hESCs after enzymatic dissociation; however, prolonging inhibition attenuated cell-cell 
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contact and gradually increased apoptosis [89, 90]. Importantly, they demonstrated that an 
overexpression of E-cadherin in NMMII-depleted hESCs was able to recover cell-cell 
contact and overall colony formation as well as to reverse the downregulation of 
pluripotency markers [89]. This suggests that cell-cell contact and colony formation are 
beneficial to long-term survival and maintenance of the pluripotent state of hESCs.  
NMMII: Mechanical Motor Modulating Cellular Function and Cytoskeleton  
NMMII is known as the critical mechanical motor of a cell because of its integral 
role in remodeling the cytoskeletal architecture for cellular adhesion, motility, 
morphology, and overall modulation of polarity [46]. The actomyosin cytoskeleton is 
intricately connected throughout the cytoplasm, from the membrane to the nucleus (Figure 
2.1) [91]. Consequently, when physical cues from the ECM or adjacent cells are sensed by 
the mechanosensory machinery, pathways such as Rho/ROCK are up-regulated to activate 
NMMII, which then helps reorganize the cytoskeleton architecture (Figure 2.2) [92, 93]. It 
is hypothesized that altering the cytoskeleton architecture affects organelle localization and 
nuclear conformation, thus mediating transcription regulations vital for the fate of stem 
cells [47, 94].  
Earlier studies that evidenced critical involvement of NMMII and pioneered the 
field of stem cell mechanobiology were conducted using hMSCs. McBeath et al. [37] 
examined how directed cell shapes contributed to hMSCs’ commitment to osteoblast or 
adipocyte. Using a surface micropatterning technique to control cell shape and the degree 
of cytoskeletal tension, the group observed that cytoskeletal tension was the driving force 
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of lineage commitment [37]. Furthermore, cell shape and tension were highly regulated by 
Rho/ROCK activity on the actomyosin cytoskeleton; in fact, it was the NMMII-mediated 
spreading and contracting mechanism that controlled differentiation pathways regardless 
of soluble differentiation factors [39]. Engler et al. [38] also showed that NMMII activity 
directed naive hMSC lineage commitment, but in this case, it was the matrix elasticity that 
dictated cell morphology by modulating NMMII activity and consequently cytoskeletal 
structure. This cytoskeletal remodeling coincided with a dramatic change in transcriptional 
regulation, resulting in lineage commitment toward a cell type whose elastic modulus was 
similar to that of the underlying substrate [38].  
Micromechanical Control of hPSC Fate 
Given the multifaceted factors influencing stem cell regulations, numerous 
strategies have been explored to efficiently control cellular function for proliferation and 
differentiation [95-98]. Certainly, the lack of efficiency has always been a major issue for 
stem cell culture. Accordingly, researchers have been and are still developing methods to 
efficiently expand and/or differentiate stem cells with a high purity of the desired 
phenotype [99-104]. At an early stage, hESC culture relied on feeder cells and serum-
supplemented media for continuous self-renewal. Since then, many chemically defined 
culture systems have been developed, eliminating exogenous undefined factors and animal 
products that are potentially problematic for clinical applications [98, 105-108]. For 
instance, Saha et al. [108] engineered ultraviolet/ozone modified polystyrene surface 
patterns, which in combination with human serum or recombinant vitronectin coating 
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improved long-term growth of hPSCs. By controlling colony size with the developed 
technology, the group was able to achieve at least a threefold increase in cell number 
compared with a conventional culture employing feeder cells [108]. Although the 
physically controlled colony size likely modulated exposure to soluble factors and cell-cell 
interactions, detailed mechanisms explaining the observed effects were not fully 
understood. 
Unlike murine ESCs, which reportedly favor a soft substrate whose stiffness is 
close to the intrinsic cytoplasmic value (~0.6 kPa) for sustaining self-renewal [58, 59], 
hPSCs seem to favor stiff ones. Musah et al. [109] sought to determine an optimal 
mechanical property of engineered substrates for supporting pluripotency and robust 
proliferation of hESCs. By using a stiff polyacrylamide hydrogel (10 kPa) conjugated with 
glycosaminoglycans (GAG)-binding peptides, the group saw more robust attachment, 
growth, and maintenance of pluripotency compared with hydrogels of identical stiffness 
(10 kPa) conjugated with integrin-binding RGD peptides or a softer hydrogel substrate (0.7 
kPa) conjugated with the GAG-binding peptides. In addition, they speculated that 
activation of YAP/TAZ in the nucleus was essential for pluripotency; as such, they saw a 
higher YAP/TAZ activation on the stiffer hydrogel than on the softer hydrogel. 
Interestingly, when plated on hydrogels with an intermediate stiffness (3 kPa), the cells 
attached and formed colonies in a similar manner as on the stiffest hydrogel (10 kPa) but 
began to detach from the substrate in the middle region of the colony in subsequent days. 
This suggests that although the intermediate stiffness can facilitate cell anchoring and 
colony formation, it is not supportive of cell spreading and continuous self-renewal [109]. 
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Lee et al. [110] also demonstrated that substrate properties could significantly affect hESC 
culture through a survey of multiple permeable membranes whose surface hardness was 
dictated by their material and pore density. They reported that a polyethylene terephthalate 
membrane with a pore density of 4 × 106 pores/ cm2 and hardness of 0.3 GPa was able to 
support cell attachment and growth of undifferentiated hESCs [110]. However, because the 
mechanical property of the membrane was coupled with the pore density and thus its 
permeability, one cannot conclude that hardness alone was the cause of the observed 
hESCs’ response. In an attempt to decouple mechanical properties of the substrate, Sun et 
al. [111] employed a polydimethylsiloxane micro-post array, which allowed for tuning 
effective Young’s moduli by changing the post height without altering contact surface area, 
matrix porosity, or surface chemistry. In this study, they showed that rigid substrates (>15 
kPa) promoted growth, colony formation, and maintenance of undifferentiated hESCs 
(Figure 2.3A) [111]. In a different study, the same group explored the ability of hESCs to 
feel nanotopography by culturing the cells on a smooth surface or a rough surface [112]. 
Results from their nanotopography tests showed that hESCs alter the patterns of their focal 
adhesion formation in response to the underlying surface texture. Specifically, hESCs 
cultured on a smooth surface resulted in a focal adhesion formation on the periphery of the 
cell, whereas a random distribution of focal adhesion was observed for hESCs cultured on 
the rough surface (Figure 2.3B). Moreover, hESCs cultured on a smooth surface were able 
to spread, form colonies, and self-renewal, whereas hESCs cultured on rough surface 
exhibited a decrease in adhesion rate, colony size, and pluripotency [112]. These results 
collectively show that defined physical properties of the ECM and substrates can cause a 
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cellular response, which critically affects hPSC growth, undifferentiation, and colony 
formation. In addition, these processes are mediated by the mechanosensory machinery 
and NMMII activity in hPSC, as is the case in hMSC. Similarly, differentiation of hPSCs 
could be influenced by the substrate’s mechanical properties. Recently, Keung et al. 
demonstrated that a soft polyacrylamide hydrogel substrate up-regulated early neural 
marker SOX1 in the absence of extrinsic neural inducers [113, 114]. However, the effect 
was limited to the first stage of differentiation, and further downstream differentiation 
required soluble neural factors. Interestingly, they observed that at different substrate 
stiffness, the cells’ proliferation rate and pluripotency did not vary during the first 3 days 
of culture, although colonies were significantly smaller and more compact on the softer 
ECM (0.1 kPa) than on the more rigid one (75 kPa). Nevertheless, the soft 
microenvironment promoted neural differentiation better than the rigid substrate, 
suggesting that the compact colony formation had a higher impact on differentiation than 
spread colonies did as seen on the rigid substrate [114, 115]. 
During embryogenesis, mechanical forces are particularly important for lineage 
specification to the primary germ layer: mesoderm, endoderm, and ectoderm [14, 32]. 
Zoldan et al. [116] studied how mechanical properties of a variety of 3D porous polymer 
scaffolds in vitro can guide hESCs into either one of the germ layers. The group reported 
hESCs remained undifferentiated in the scaffold with the highest elasticity (>6 MPa), 
suggesting it supports maintenance of pluripotency. In addition, the group observed that 
hESCs cultured on substrates with high (1.5–6 MPa), intermediate (0.1–1 MPa), and low 
(<0.1 MPa) elasticity expressed gene markers specific for mesodermal, endodermal, and 
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ectodermal differentiation, respectively. They speculated that the scaffold elasticity 
affected the motility, traction force, and cytoskeletal tension and that the modulation of 
such cellular conditions could result in changes in morphology, adhesion to the ECM, cell-
cell contact, and transcription relevant to differentiation, thus allowing hESCs to adjust to 
the microenvironment [116]. 
Other engineered micromechanical environments have been employed to explore 
optimal mechanical conditions to direct hPSC fate. For instance, Chan et al. [117] 
demonstrated how a specific topography could influence neural differentiation of hPSCs, 
even in the absence of chemical differentiation factors. They cultured hESCs on a 2 µm 
pitch, linear grating and observed cell and colony morphology being elongated along the 
grating direction, mimicking a neural lineage state even in a chemical condition promoting 
the undifferentiated state (Figure 2.3C). When cultured in differentiation-inducing media, 
hPSCs quickly committed to a neural lineage, showing the collaborative effect of both 
physical and chemical cues [117]. The synergistic role of chemical cues and physical cues 
presents great potential for leveraging control of hPSCs by the engineered 
microenvironment; however, identifying optimal cross-talk brings the need for screening 
multiple physical cues that support differentiation into many cell types [41, 118]. For this 
reason, Ankam et al. [119] developed a multiarchitecture chip (MARC) to screen multiple 
combinations of topography designs specifically for ectoderm differentiation. The 
multitude of topography designs in the MARC varies in geometry such as gratings, pillars, 
and wells, as well as their 3D dimension. Overall, they observed that neuronal fate was 
highly favored on anisotropic geometries, such as linear gratings, where cell morphology 
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was aligned and elongated along the grating direction, inducing neuronal differentiation. 
In contrast, they observed that glial fate was promoted on isotropic geometries such as 
pillars and wells, where the cells stayed round and spread along all direction of the 
patterned substrate (Figure 2.3C) [119]. The spreading morphology of hESCs on pillars 
was also observed by Kong et al. [120], however, in this study, a higher percentage of 
OCT4 (a marker of undifferentiated state) was observed in cells cultured under hexagonal 
and honeycomb pillar lattice configuration. It was suggested that the pillar patterns 
attenuated focal adhesion formation to shift dependency on cell-cell contact for survival 
and self-renewal [120]. Altogether, physical cues such as substrate stiffness and 
topography have a profound impact on hPSC regulation, which in turn can dictate its 
survival, self-renewal, or differentiation. Recent demonstrations of hPSC control using 
micromechanical environments are summarized in Table 2.1. 
Summary and Future Perspective 
With help from recent progress in micro- and nanotools and technologies, 
researchers are beginning to understand the mechanobiology of hPSCs and specific 
physical cues associated with cellular regulations. For instance, similar to hMSCs, it is now 
evident that hPSCs are equipped with molecular machinery for sensing various physical 
cues in their surroundings. These mechanosensors are essential interpreters of cell-ECM 
and cell-cell physical interactions and translate physical cues into intracellular biochemical 
signals. Subsequently, the biochemical signals can direct many cellular activities such as 
regulating cell polarity for cell migration, contraction, or expansion. Changes in cell 
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polarity are regulated by the NMMII activity. In addition, the cytoskeletal tension produced 
by hPSCs can dictate regulations for survival, self-renewal, pluripotency, and lineage 
specification. For this reason, some have tried to characterize the intracellular mechanics 
of hPSCs and their differentiated derivatives to uncover mechanical phenotypes indicative 
of hPSC lineage specification [121-123]. Nevertheless, investigation of hPSC 
mechanobiology is still at an early stage, and much remains to be uncovered. For example, 
the majority of work done so far has only probed the effects of physical cues on either 
maintenance of pluripotency or initial commitment to differentiation lineages but not on 
long-term, terminal differentiation into fully mature cells. As the core value of hPSCs is 
their ability to differentiate into many, if not all, types of human tissues, understanding 
roles of physical cues in downstream differentiation will be particularly important for basic 
science as well as for clinical applications in which such knowledge is required to fully 
exploit differentiation potential of the cells. 
To further investigate the impact of individual physical cues, new tools that allow 
for decoupling of physical properties and high-throughput screening methods will be 
desired. Innovative platforms such as the MARC [119] and TopoChip [124] have shown 
great promise by enabling high-throughput screening of defined topography on a single 
platform. However, as the density of test beds on chip increases, precise fluid handling 
(e.g., media exchange without chemical cross-talk among neighboring test sites) analytical 
measurement technique beyond simple immunostaining and fluorescence measurement on-
chip needs to be developed. In particular, passaging cells in a multistep differentiation 
process, in which chemical stimulants are sequentially changed according to specific stages 
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down the lineage commitment, will be extremely challenging in a high-throughput array 
format. Furthermore, upon successfully identifying potent physical factors that affect hPSC 
fate, screening of combinatorial cues of both physical and chemical factors should take 
place. Given that the in vivo stem cell niche comprises dynamic signaling of chemical and 
physical cues, an optimal microenvironment in vitro would most likely require a 
combination of multiple factors to unleash the full potential of the stem cell by maximizing 
synergistic effects. However, the factorial of multiple chemical and physical parameters 
suffers from an exponentially large combinatorial problem. To make matters worse, 
factoring timing as one of the parameters will inevitably make the challenge almost 
impossible. Therefore, new innovations, perhaps as a combination of nanofabrication, fluid 
handling, molecular imaging, automation, and an optimization algorithm, will be necessary 
to complete such an extremely daunting task.  
In addition, from the point of view of hPSC-based cell therapy, culture methods 
need to be scaled up to supply a clinically relevant number of transplantable cells. Three-
dimensional cultures in which hPSCs are cultured within a scaffold or suspended as clusters 
with or without microcarriers in a culture medium are the likely solutions to meet such 
demands at a reasonable cost. However, on such a platform, implementing physical cues 
such as defined surface topography or matrix stiffness would be difficult and require the 
development of a whole new set of engineered tools and technologies to harness physical 
cues to control of stem cell fate.  
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All of these requirements highlight the fact that mechanobiology of hPSCs is a truly 
multidisciplinary field and offers a unique opportunity for exciting collaborations among 
stem cell biologists, chemists, materials scientists, physicists, engineers, and more. 
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Table & Figures 
II Table 2.1. List of engineered micromechanical cues affecting human pluripotent stem 
cells 
 
 
Mechanical 
Environment 
Effects on hPSC Fate Cell Lines Reference 
Surface 
Roughness 
Nanoscale surface roughness induced spontaneous 
differentiation, whereas a smooth surface promoted self-
renewal and long-term pluripotency. 
hESC (H9) 112 
Substrate 
Elasticity and 
Stiffness 
Polyethylene terephthalate (PET) membrane with a 
defined porous density at 4 x 106 pores/cm2 and stiffness 
at 0.3 GPa promoted self-renewal and growth, in 
addition to uniform colony formation. 
hESC (HSF6, H9, 
Miz4, Miz6) 
110 
Rigid polyacrylamide hydrogel (10 kPa) coated with 
GAG-binding peptides supported optimal hESC 
adhesion, self-renewal, proliferation and long-term 
maintenance of pluripotency. 
hESC (H9) 109 
Higher stiffness of PDMS micropost arrays resulted in 
increased hESC traction force, cellular adhesion and 
maintenance of pluripotency. 
hESC (H1, H9) 111 
Soft polyacrylamide hydrogel substrate (0.1 kPa) promoted 
early differentiation to neural lineages. 
hESC (H1), hiPSC 
(MSC-iPS) 
114 
3D scaffolds with low (<0.1 MPa), intermediate (0.1-1 
MPa) and high elasticity (1.5-6 MPa) promoted 
expression of ectoderm, endoderm, and mesoderm 
markers, respectively. 
hESC (H9) 116 
Topographical 
Patterns 
350 nm ridge/groove patterns directed differentiation to 
neural lineage without biochemical differentiation 
factors. 
hESC (H9) 41 
2 µm grating patterns increased the rate and efficiency of 
early and mature neural differentiation. 
hESC (HES-3, H7), 
hiPSC (iPS-IMR90) 
117 
Surface grating promoted neuronal differentiation, whereas 
pillars and wells promoted glial differentiation. 
hESC (H1, H9) 119 
Nanopillar lattices with hexagonal or honeycomb 
configuration maintained high expression of pluripotent 
marker OCT4 even in the absence of bFGF. 
hESC (H1) 120 
Directed Colony 
Shape and Size 
Size-controlled colonies at 300 µm diameter expanded 
faster and showed higher expression of pluripotency 
markers compared to colonies on feeder layers. 
hESC (BG01, 
WIBR1, WIBR3), 
hIPSC (C1-iPS) 
108 
Size-controlled colonies resulted in higher percentage of 
population that are double-positive against TRA 1-81 
and each of OCT4, NANOG and SOX2 compared to 
colonies on feeder layers. 
hESC (HSF1, H9) 104 
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Figure 2.1. Cell mechanical regulations simplified. Cellular adhesion to extracellular 
matrix and adjacent cells are regulated by integrins at the focal adhesion and by cadherins 
at the adherens junction, respectively. Inside the cell, both integrin and cadherin are 
integrated with the actin cytoskeleton mediated by other proteins such as focal adhesion 
complex for integrins and b-catenin for cadherins. The actin cytoskeleton supports the cell 
structure and shape throughout the cytoplasm. When intracellular activity signals to alter 
cell polarity, nonmuscle myosin II (NMMII) mediates reorganization of actin cytoskeletal 
tension and induces changes in cell morphology.  
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Figure 2.2. Mechanics of cell–extracellular matrix (ECM) and cell-cell interactions. 
Mediated by nonmuscle myosin II (NMMII), forces exerted by the ECM and neighboring 
cells can affect contraction or elongation. In turn, local deformation of the cell and the 
ECM can be dictated by their mechanical properties and number of cell-ECM and cell-cell 
force interactions.  
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Figure 2.3. Substrate mechanical properties affecting the behavior of human pluripotent 
stem cells. (A) Soft substrates lead to a decrease in traction force and compact single-cell 
and colony morphologies (top), whereas rigid substrates lead to an increase in traction force 
at the peripheral regions of the cell, resulting in an increased single-cell and colony 
spreading (bottom). (B) Nanoscale rough surfaces result in compact single-cell and colony 
morphologies due to randomly distributed focal adhesion formations and decreased cellular 
adhesion to the extracellular matrix (top). On the other hand, smooth surfaces result in 
increased single-cell and colony spreading where focal adhesion formations are distributed 
along the periphery of the cells (bottom). (C) Anisotropic topographical patterns influence 
single-cell and colony morphologies to elongate along the feature direction (top), whereas 
isotropic patterns, result in rounded morphologies with fewer focal adhesion formations 
(bottom). (Illustrations made based on findings in refs. 109, 111, 112, 114, 117, 119, and 
120).  
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CHAPTER 3: 
INITIAL STUDIES INTO STATIC AND STIRRED SUSPENSION 
CULTURES AND HOW THE HYDRODYNAMIC ENVIRONMENT 
CAN AFFECT PLURIPOTENT STEM CELLS IN SUSPENSION 
Abstract 
An alternative to conventional 2D adherent cultures, 3D suspension cultures are among 
one of the most promising methods for large-scale production of hESCs and their 
derivatives. Specifically, 3D suspension as aggregate cultures is advantageous because it 
allows easy handling of hESC while maintaining native-like 3D cell-cell contact without 
the need of xenogeneic materials. In this study, we first evaluate the optimal growth 
medium to use for our subsequent study and found mTeSR1 to be the superior medium for 
large-scale expansion of hESC in suspension. We then conducted a 2-part study using a 
conventional stirring vessel to investigate the influence of agitation rates, ranging from 0 
rpm (static) to 120 rpm, on the propagation of hESCs in dynamic suspension culture. In 
part 1, the cells were first grown under static suspension conditions for 2 days, then 
agitation condition for the next 5. In part 2, agitation was initiated on day 0 after single-
cell inoculation. Overall, we found the best agitation condition to improve cell yield is the 
one that limits production of large-sized aggregates. For this reason, we sought to 
understand the physical parameters of fluid mixing and its influence on aggregation, 
viability and other responses that could be exploited to improve and control the culture 
outcome. 
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Optimization of basal media in static suspension culture of hESCs 
A number of publications describing static and dynamic 3D suspension culture of 
human pluripotent stem cells have been recently reported. Amit et al. developed a protocol 
that achieved long-term culture for multiple hPSC lines, plus a 25-fold expansion within 
10 days, by producing a medium consisting of DMEM/F12 and KO-serum replacement 
(KO-SR) as the basal medium, and supplemented with a mix concentrations of bFGF and 
IL6RIL6 chimera as the main factors to support hPSC’s growth in suspension [1]. 
Similarly, Steiner et al. also developed a protocol that utilized Neurobasal medium with 
KO-SR and supplemented with growth factors Activin A and bFGF, plus solubilized 
extracellular matrix (ECM) laminin and fibronectin to support propagation of multiple 
hESC lines as floating aggregates [2]. However, the medium used in Amit et al. and Steiner 
et al. may not be cost-effective and efficient to produce and store for industrialization. 
Further improvements need to be recognized for good manufacturing practice (GMP). 
Other groups have also had some success in growing hPSC in suspension cultures, but 
unlike Amit et al. and Steiner et al., a common commercially available medium such as 
mTeSR or StemPro was implemented for expansion of hPSC in suspension [3-5].  
In our preliminary study, we assessed static suspension culture to select an optimal 
medium to be used for subsequent studies and demonstrate that routine suspension culture 
and standard cellular and molecular analyses are feasible. 
We evaluated four medias, three of which are commercially available media 
formulations - mTeSR1, StemPro with 40ng/ml of bFGF, and Essential 8 (E8) - plus a 
modified formulation from Steiner et al. which we call Neurobasal Cocktail [2]. To initiate 
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our suspension culture, we pre-treated monolayer cultures of hESC that had been stably 
transfected with an OCT4-eGFP reporter with 10µM of ROCK inhibitor (ROCKi) for at 
least l hr before trypsinization. After trypsinization, single cells were seeded at a 
concentration of 1×105 cells/ml in 4 ml of the respective four media supplemented with 
10µM of ROCKi. ROCKi significantly improved the survival of single cells and promoted 
the formation of aggregates. We discontinued ROCKi treatments on day 4 and allowed the 
cells to depend on their cell-cell interactions for survival. We measured daily expansion 
rate up to 7 days and examined the aggregation sizes as well as expression of OCT-4 and 
SSEA3 pluripotent markers. 
At the end of our culture time point (day 7), growth curve revealed an increase in 
cell number even after the withdrawal of ROCKi on day 4 (Figure 3.1A). The growth curve 
was assessed by daily cell count of triplicate samples for each condition and in terms of 
fold increase, which is a function of the cell density output divided by the initial cell density 
on day 0. Overall, mTeSR1 resulted in the highest cell yield producing up to 19 fold 
increase, followed by StemPro medium at 12 fold increase, E8 medium at 8 fold increase, 
and Neurobasal cocktail producing the lowest cell yield (1.5 folds) after 7 days of culture 
(Figure 3.1A). Upon observing the aggregate culture, the aggregate morphology was 
observed to be notably different from each growth medium (Figure 3.1B). Aggregates in 
mTeSR and StemPro were more spherical with sizes ranging from 100 µm to roughly 400 
µm. Large sized clusters (> 500 µm) were also apparent and oddly shaped, likely the result 
of individual aggregates agglomerating to form larger clusters as observed by previous 
reports [3-5]. In contrast, the other two media produced smaller sized aggregates, but the 
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E8 generated more spherical shaped aggregates while Neurobasal Cocktail aggregates were 
less spherical and more cumulus cloud-like morphology. Interestingly, while assessing 
their OCT4-eGFP reporter by fluorescent microscopy, certain regions of the aggregates 
showed a decrease in OCT4-eGFP fluorescent (Figure 3.1B). In particular, we observed 
this to be more abundant in the mTeSR culture and the Neurobasal Cocktail, which 
suggests a loss of the pluripotent characteristics of the cells. However, single-cell analysis 
of the OCT4-eGFP expression revealed that only the cells in the Neurobasal Cocktail 
resulted in a significant decrease in OCT4 pluripotent marker (61.5%), as evidenced by 
flow cytometry (Figure 3.1C). mTeSR, on the other hand, resulted in the highest OCT4 
expression at 88.6%, followed by StemPro (82.8%), then E8 (77.7%) (Figure 3.1C). 
Results of the SSEA3 analysis further confirmed that both mTeSR and StemPro were 
superior in supporting the growth and maintenance of hESC, whereas the E8 and 
neurobasal cocktail was not able to fully support their undifferentiated state. As such, 
mTeSR was chosen over StemPro to be the media of choice for subsequent scale-up study 
because of its performance in growth and maintenance of pluripotency after 7 days in static 
suspension culture. Not to mention that the components to make mTeSR have been fully 
publicized and is considered to be the ideal system to modify in the future, whereas 
StemPro is a proprietary medium.  
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The effects of agitation in stirred suspension culture of hESCs 
Because of the limitations in static suspension (e.g. excessive agglomeration), we 
utilized Corning 125 mL polystyrene disposable spinner flask as the appropriate dynamic 
culture vessel on suspended cells (Figure 3.2A). In this initial study, we wanted to evaluate 
how the hydrodynamic condition via agitation rates would impact the propagation of 
hESCs. Therefore, we tested different agitation rates, ranging from 0 rpm (static) to 120 
rpm, on a H9.OCT4-eGFP reporter line suspended in mTeSR and cultured for 7 days in 
the stirring vessel. We conducted two separate studies, in which the initial condition was 
different between the two (Figure 3.2B). In part 1, we paused agitation and allowed the 
cells to grow in static conditions for the first 2 days of culture, and then in agitation 
conditions for the next 5 days of culture. In part 2, the respective agitation condition was 
initiated on day 0 after single cell inoculation and continued the culture up to the end of 
our study (day 7). The starting procedure for both studies was the same and similar to our 
previous static suspension study where the vessel was seeded at a concentration of 1x105 
cells/ml in 50 ml of mTeSR supplemented with 10 µM of ROCKi. As noted in our previous 
study, cell growth was determined in terms of fold increase, which is a function of the cell 
density output divided by the initial cell density on day 0.  
For the first part of the study, the 0 rpm and 80-120 rpm all produced similar cell 
yield resulting in ~11 fold increase after 7 days of culture, while 40 and 60 rpm produced 
4.5 fold and 7 fold increase, respectively (Figure 3.3A). The 20 rpm condition generated 
the lowest cell yield among the other conditions with only 2 fold increase. Interestingly, 
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although differences in growth curve were apparent, flow cytometry analysis showed little 
variation in pluripotent marker expression between each condition (Figure 3.3B). On the 
other hand, aggregate morphology and size distribution had varying results (Figure 3.3C). 
The size distribution at 0 rpm was smaller than at 60-120 rpm where distribution varied 
greatly, but the majority of sizes were between 400-800 µm. The 20 rpm and 40 rpm 
condition had a much larger size distribution, and thus, produced the lowest cell yield.  
For part 2 of the study, the highest growth curve was observed only in the 100 rpm 
condition (16.7 fold increase), followed by 0 rpm and 120 rpm condition resulting in 12 
fold and 11.5 fold increase, respectively (Figure 3.4A). Again, the lowest growth curve 
was observed in the 20 rpm and 40 rpm, where both conditions resulted in less than 2 fold 
increase. Similar to part 1, flow cytometry analysis showed the majority of the cells still 
retained high levels of pluripotent markers, but the 20 and 40 rpm did have a slight drop in 
expression (Figure 3.4B). However, apart from the 0 rpm condition, aggregate formation, 
and size distribution were notably different in part 2, with smaller sized aggregates being 
more abundant in each condition (Figure 3.4C). Interestingly, similar to part 1 of the study, 
20 rpm and 40 rpm produced larger-sized aggregates than any other conditions. This 
presents an interesting finding in which the condition that produced the lowest cell yield 
also produced the largest size distribution (20 and 40 rpm). In contrast, the condition that 
generated the highest cell yield had minimal large-sized aggregates (> 500 µm) and more 
homogenous size distribution between 200-400 µm.  
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The difference in part 1 & 2 of our study is the initial growth condition. For this 
reason, higher agitation rates were more tolerable in part 1 where we observed similar 
results from 80-120 rpm. The initial aggregate formation improved viability when the cells 
were exposed to agitation following 2 days in static suspension. As such, we observed 
higher cell yield at the 20 and 40 rpm for part 1 of the study compared to part 2. In contrast, 
the overall growth at 80-120 rpm for part 1 was notably less in comparison to the 100 rpm 
in part 2 of the study. The reason for this result could likely be explained by the differences 
in aggregate size distribution between the two studies. In particular, part 1 size distribution 
was more heterogeneous than compared to part 2 where we observed the majority of the 
aggregates to be less than 500 µm. Collectively, in part 2 of the study, it appears that the 
mixing condition facilitated the initial aggregate formation and regulated the overall size 
distribution by the end of the culture time point to improve the cell yield. These results 
suggest aggregation and regulating the aggregate size is a key parameter that must be 
controlled in stirred suspension systems. As such, we will discuss some working theories 
of how the fluid mixing could impact aggregation, viability and other cellular response of 
hPSCs to rationalize our stirred suspension results.  
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How the hydrodynamic environment could affect cellular responses of hPSCs 
 In 2D cultures, hPSCs adhere to ECM-coated surfaces and form colonies for 
survival and growth. In 3D aggregate suspension culture, there are no surface or 
microcarriers that hPSCs could adhere to, so they form free-floating aggregate spheroids 
via binding of the E-cadherin transmembrane proteins that are ubiquitously expressed by 
pluripotent stem cells [6]. In static suspension (0 rpm), cell aggregate formation is based 
on the proximity of neighboring cells freely floating in the medium. As such, 
agglomeration often occurs in a stochastic manner resulting in variation of aggregate sizes 
and shapes in the culture. In stirred suspension cultures, the initial aggregate formation, 
whereby single cells come together and assemble via cell-cell adhesion, and the overall 
aggregate size over the course of culture time point, are controlled by the hydrodynamic 
mixing condition. With hydrodynamic mixing, convective force enhances the mass transfer 
of the system that could force more frequent cell-cell interactions bound by the fluidic 
motion. For this reason, in comparison to static suspension, some have proposed that 
aggregate sizes could be correlated with the increased in transport parameters in stirred 
suspension cultures [7, 8]. However, the mass transfer coefficient is known to increase as 
a power function of the impeller speed with specific parameters given by the fluid and 
geometrical properties of the culture system [9, 10]. This means that aggregation dynamics 
is also a function of the fluid properties and design of the culture vessel. As a result, 
differently designed systems could produce different aggregate sizes under similar 
agitation rate. Also, the inoculation density is another parameter that could impact 
aggregation dynamics since the frequency of cell-cell interactions is also dependent on the 
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cell density in suspension [11]. Nevertheless, the hydrodynamic environment dictates how 
the cells aggregate for survival, and a fine balance must exist between mixing conditions 
necessary to control aggregation/size and limiting excessive shear force related cell death. 
For this reason, understanding the hydrodynamic parameters in a basic stirred suspension 
system will be useful for future designs of the system to control hPSCs culture.  
An important consideration in stirred suspension culture of hPSCs is understanding 
how shear force can be a critical component in dynamic suspension systems. The current 
model to calculate the maximum shear stress (𝜏max) [12] the cells experience in suspension 
can be estimated from 
τmax = 5.33ρ(ɛν)
1/2              (1) 
where ρ is the medium density, ν is the fluid kinematic viscosity, and ɛ is the viscous 
energy dissipation per unit mass. Both ρ and ν are medium properties that could be 
determined, whereas ɛ is calculated by  
ɛ =
P
VLρ
       (2) 
VL represents the working volume of the spinner culture flask, and P is the impeller power 
input. The power input could be estimated by the following equation 
   P = Np(N
3)(Di
5)ρ                  (3) 
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where N is the agitation rate and Di being the impeller diameter. The corresponding Np is 
the dimensionless power number that can be calculated as a function of the impeller width 
(W), impeller diameter (Di), and vessel diameter (Dt) that was proposed by Nagata [13] for 
bladed paddle impellers in an unbaffled tank: 
Np =
A
Re⁄ + B (
103+1.2Re0.66
103+3.2Re0.66
)
p
         (4) 
Where coefficient A, B, and p are given by: 
A = 14 + (
W
Dt
) [670 (
Di
Dt
-0.6)
2
+ 185]      (5) 
B = 10^ {1.3-4 (
W
Dt
-0.5)
2
-1.14 (
Di
Dt
)}                  (6) 
p = 1.1 + 4 (
W
Dt
) -2.5 (
Di
Dt
-0.5)
2
-7 (
W
Dt
)
4
                (7) 
The Reynolds number (Re) in a stirring vessel could be found as a function of the agitation 
rate, impeller diameter, and kinematic viscosity through 
Re =
(N)(Di
2)
ν
               (8) 
At sufficiently high Reynolds numbers, the kinematic viscosity (ν) and viscous energy 
dissipation (ɛ) could also be used to calculate the smallest terminal eddies (η), also known 
as Kolmogorov eddies [14], given by 
η = (ν3 ɛ⁄ )1/4                              (9) 
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Agitation results in a transfer of energy from the impeller to the liquid. As the impeller 
moves through the liquid, primary turbulence is formed and disintegrates to form cascades 
of small intense turbulence (Kolmogoroff eddies) to dissipates the energy [15, 16]. As 
agitation increases, the eddy size decreases and creates high localized shear that could be 
detrimental to the cells [17, 18]. Damage occurs when the size of the eddy is similar to the 
size of the suspended particle, and thus, the local shear affects the cells residing on the 
surface of the aggregates in suspension [19, 20]. However, if the aggregate is smaller than 
the Kolmogorov eddies, the aggregate would be confined within and transported along with 
the eddy, thereby limiting the cells encounter to the local surface shear [21]. For this reason, 
single cells in suspension are generally not affected by the eddy since the size a cell are 
typically much smaller than the size of eddies, unless at impractically intense agitation. 
 Altogether, previous studies have suggested that Kolmogorov eddies are 
responsible for controlling aggregate size in suspension [16]. Specifically, if the aggregate 
size (diameter) is greater than the size of eddies, the cells on the surface could experience 
enough shear force to dislodge it from the aggregate. Since both aggregate size and eddy 
size are the result of the hydrodynamic condition, the correlation between maximum mean 
aggregate size and energy dissipation have been previously investigated using different cell 
types [7, 8]. It was found that there is some relationship between aggregate size and 
Kolmogoroff eddy scale governed by the energy dissipation rate. However, Sen et al. report 
that the Kolmogoroff eddy is only partially responsible for the aggregate size [8]. Reports 
indicate that a certain ratio of eddy size to aggregate size is necessary for the local shear to 
have an impact on the surface of the cells [21, 22]. We attempted to understand this 
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mechanism by correlating our specific parameters, such as fluid viscosity and dimensions 
of the polystyrene disposable flask, with our observed aggregate size distribution as 
suggested by Sen et al. [8]. However, our findings were inconclusive since aggregate size 
were only observed at the end point of our culture (day 7) where we found a number of 
large aggregates that did not match our calculation (Appendix A).   
 Certainly, it is the mixing speed that can ultimately change aggregate sizes, with 
slower rates producing larger size aggregates and faster rates producing smaller size 
aggregates. However, previous studies suggest that shear stress could modulate the kinetics 
of E-cadherin interactions [6]. It was found that E-cadherin bonds between cells could 
readily be broken under mechanical stress [23]. Modulation of adhesion receptors such as 
E-cadherin can have great implications to downstream signaling pathways that could 
influence hPSCs fate decisions. Mainly, β-catenin mediates E-cadherin intercellular 
adhesion, but changes in E-cadherin activity could result to free β-catenin functioning as 
part of the canonical WNT pathway [24]. This WNT/β-catenin signaling pathways is 
known to promote lineage-specific differentiation of hPSCs [25]. Therefore, it’s possible 
that aggregation and the process in which agitation-induced shear stress act as a signaling 
cue via E-cadherin could be inter-related. 
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Figures 
Figure 3.1. Comparison of four growth media on hESCs expansion under static 
suspension. (A) Daily growth curves in terms of fold increase. (B) Bright field and OCT4-
eGFP fluorescent microscopy of cell aggregates after 7 days of culture. Scale bars: 250 
µm. (C) Flow cytometry analysis of OCT4 and SSEA3 pluripotency markers. 
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Figure 3.2. Experimental set-up of our initial study into stirred suspension culture. (A) Set-
up of the Corning 125 mL polystyrene disposable spinner flask. (B) Schematic of testing 
varying agitation rates in two separate studies. In part 1, all of the conditions are cultured 
in static suspension for the first 2 days, then in their agitation condition for the next 5 days. 
In part 2, agitation was occurred on day 0 to culture end-point, day 7.    
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Figure 3.3. Part 1 results of different agitation rates (0-120 rpm) for the propagation of 
hESC in stirred suspension culture. (A) Growth curve by daily cell counting for each 
agitation condition. (B) Flow cytometry analysis of OCT4 and TRA-1-60 pluripotency 
markers. (C) Aggregate formation and quantitative analysis of aggregate size distribution 
for the different agitation rates. Results at 20 rpm not available due to excessive 
agglomeration resulting in an insufficient data. Scale bars: 150 µm   
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Figure 3.4. Part 2 results of different agitation rates (0-120 rpm) for the propagation of 
hESC in stirred suspension culture. (A) Growth curve by daily cell counting for each 
agitation condition. (B) Flow cytometry analysis of OCT4, SSEA4 and TRA-1-60 
pluripotency markers. (C) Aggregate formation and quantitative analysis of aggregate size 
distribution for the different agitation rates. Scale bars: 250 µm 
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 CHAPTER 4: 
IMPACT OF FLUIDIC AGITATION ON HUMAN PLURIPOTENT 
STEM CELLS IN STIRRED SUSPENSION CULTURE 
Abstract 
In the current study, we used the 125 mL ProCulture glass spinner flask to systematically 
investigated various agitation rates and characterize their impact on cell yield, viability, 
and maintenance of pluripotency. After 7 days of dynamic suspension culture, moderate 
agitation (60 rpm) was found to produce the highest cell yield (30-40 fold increase) of 
undifferentiated hPSCs. We then closely examined the distribution of cell aggregates 
between each condition and evaluated how the observed culture outcomes are attributed to 
their size distribution. Overall, our results showed that moderate agitation maximized the 
propagation of hPSCs by limiting cell death caused by excessive fluidic forces and 
controlling the cell aggregates below the critical size (< 400 µm), beyond which the cells 
suffer from diffusional limitations. Furthermore, we observed that fluidic agitation could 
regulate not only cell aggregation, but also expression of some key signaling proteins in 
hPSCs. This study suggests that fluidic agitation could be a considerable input parameter 
to facilitate fate determination in dynamic suspension cultures.    
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Introduction 
With their unique ability to expand indefinitely and differentiate into any cell type 
in the human body, human pluripotent stem cells (hPSCs) – including both human 
embryonic stem cells (hESCs) [1] and human induced-pluripotent stem cells (hiPSCs) [2, 
3] – have emerged as a promising cell source for future cell therapy applications [4]. The 
prospect of these cells is at a point where researchers can produce quality hPSC-derived 
products that could be used for pre-clinical and clinical studies [5, 6]. However, progress 
towards clinical implementation of these hPSC-derived products would be limited by the 
lack of a robust scalable system that can cost-effectively produce clinically relevant 
numbers of hPSCs and their derivatives [7]. For instance, treatments for myocardial 
infarction, type I diabetes, and neurodegenerative diseases have been estimated to require 
approximately ~109 cells per patient [8-10]. Furthermore, given the relatively low 
efficiency of in vitro directed differentiation, an even larger number of undifferentiated 
hPSCs are needed to meet the anticipated demand. Producing one billion hPSCs alone by 
traditional adherent planar culture systems is prohibitively time-consuming and expensive 
beyond research settings [11, 12].  
Over the past decade, researchers have focused on developing alternative strategies 
to produce large numbers of hPSCs in an economically feasible manner [13]. In particular, 
stirred suspension culture such as spinner flasks presents an ideal platform for large-scale 
expansion of hPSCs, where the cells often grow as aggregates. Aggregate suspension 
cultures eliminate the use of microcarriers because hPSCs adhere together and form free-
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floating spheroids for survival and growth, making this system more cost-effective for 
large-scale expansion [14]. Furthermore, stirring helps minimize heterogeneity in size of 
cell aggregates that is often observed in static suspension cultures. Reports of the successful 
demonstrations of stirred suspension culture for the expansion of undifferentiated hPSCs 
are summarized in Table 4.1. Across these studies, it was found that stirred suspension 
cultures were more effective in expansion rate and in achieving a high cell yield than static 
suspension cultures. However, the reported culture outcomes relied on empirically 
optimized conditions which varied from one system to another [15-17]. This is in part due 
to the added complexity of hydrodynamic motions present in different designs of the 
culture vessels. Furthermore, detailed characterizations of different agitation rates and their 
influence on the propagation of hPSCs were not reported in many studies. Therefore, it is 
difficult to standardize an optimal protocol for hPSCs in dynamic suspension by drawing 
a comparison across separate studies. 
In this study, we describe how different agitation rates, ranging from 0-100 rpm, 
impact the survival, growth, maintenance of pluripotency, and protein expression levels of 
hPSCs in stirred suspension. The investigation of different agitation rates was designed to 
characterize the efficacy of an optimal agitation rate in comparison to the rates above or 
below. We further investigated how the cell aggregate size attributed to the culture output. 
The current study suggests that although higher agitation rates reduce cell viability, the 
formation of large-sized cell aggregates, typically observed at lower agitation rates, 
presents a greater limiting factor in hPSCs suspension culture strategies. Another 
interesting observation in this study is varying expression levels of cell signaling proteins 
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due to fluidic agitation. This suggests fluidic-agitation-induced mechanotransduction, 
potentially opening up a new means to control stem cell fate in stirred suspension culture. 
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Materials and Methods 
Maintenance of hPSCs on 2D adherent cultures 
The hESC line H9 was obtained from WiCell Research Institute. RIV9-iPSC (from 
human foreskin fibroblast) lines were derived at the UC Riverside Stem Cell Core facility 
[18]. hPSCs were maintained in standard culture conditions (37 °C, 5% CO2, 100% 
humidity) on Geltrex (LDEV-Free, hESC-qualified, Thermo-Fisher) coated six-well plates 
(Corning) with complete mTeSR1 medium (StemCell Technologies). Cells were passaged 
every 5 to 6 days as small clumps via enzymatic treatment with Accutase (Thermo-Fisher) 
at 37 °C for 5-10 min and washed twice with DMEM (Lonza) before re-plating. Expansion 
of hPSCs was done the same way as the six-well plate but on T25 (Corning) and T75 
(Thermo-Fisher) culture flasks.  
Stirred suspension culture 
From the 2D adherent culture, hPSCs were treated with 10 μM Y-27632, an 
inhibitor of Rho-associated protein kinase (ROCKi, Roche), for 1 hr at 37 °C prior to 
enzymatic dissociation to minimize cell death caused by single-cell dissociation. The cells 
were then washed three times with 1x PBS (Hyclone), treated with 0.25% Trypsin-EDTA 
solution (Thermo-Fisher) for 10 min at 37 °C, gently pipetted to break up clumps, and 
strained through a 40 μm cell strainer (Corning) to obtain single cells. The cells were then 
diluted (1:10) using 10% fetal bovine serum (FBS, Hyclone) in DMEM (Lonza) to 
inactivate the trypsin, and spun down at 250×g for 5 min. Cells were resuspended in 
mTeSR1 medium with 10 μM ROCKi and inoculated at a density of 105 cells/mL with a 
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total volume of 50 mL per flask in Corning 125 mL ProCulture glass spinner flasks that 
had been siliconized with Sigmacote (Sigma) following the manufacturer’s instruction. A 
custom-made, four-position stirrer (bioMIXdrive4, 2mag-USA) was used to continuously 
drive the impeller of each flask at its designated agitation rate. The cells grew into and were 
maintained as aggregate spheroids for seven days. For each flask, a complete medium 
change was carried out after 24 hrs to remove ROCKi, followed by a 70% medium change 
with a fresh one on day 3. On day 4, the culture was split in half and replenished with fresh 
medium, followed by another 70% medium change on day 6.  
Daily sampling to determine fold increase  
For each condition, three 1 mL samples were taken from the spinner flask for cell 
counting and replaced with an equal amount of fresh medium. Upon enzymatic digestion, 
the cells were manually counted by the trypan blue exclusion method. The growth curve 
was generated based on the daily cell count with an adjustment to the lost volume due to 
daily sampling and the 50/50 split on day 4.  
Quantifying aggregate size distribution 
Aggregate samples were taken on day 7 and placed in a 12-mm culture dish (BD 
falcon) for photomicrographs using a Nikon D5100 camera attached to a Nikon Eclipse 
TS100 microscope. Three samples for each condition were taken and imaged. Image 
contrast and brightness were adjusted by ImageJ, and a custom MATLAB script was used 
to measure and collect the equivalent diameter of each aggregate.  
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Cell aggregate formation of prescribed sizes 
To produce aggregates of prescribed sizes, we first surveyed varying seeding 
density of single cells to determine estimated numbers of cells needed on day 0 for attaining 
aggregates of approximately 100, 200, 300, 400, and 500 µm in diameter on day 7. Single 
cells were obtained as described above. The cells were suspended in mTeSR1 with 10 μM 
ROCKi and seeded onto an ultra-low-binding 96-microwell plate with a U- or V-shaped 
bottom (Gel Company, Lipidure-Coat). The plate was centrifuged for 5 min at 400×g to 
force the initial aggregate formation and incubated in the standard culture condition. After 
24 hrs, ROCKi was removed by replacing the medium with fresh mTeSR1, and the 
aggregates were transferred to a flat bottom ultra-low-attachment microwell plate 
(Corning) for photomicrographs. Routine medium change was carried out every day by 
replacing 50% with fresh medium of mTeSR, and multiple images of the cell aggregates 
were taken every day to observe the progression of size increase. At the culture endpoint, 
the prescribed aggregates were trypsinized individually for analysis.  
Flow cytometry 
Cell aggregate samples were trypsinized into single cell as described above. The 
cells were fixed with 4% paraformaldehyde, washed with 1X PBS, and permeabilized with 
0.2% Saponin in wash buffer solution (PBS + 5% FBS) for 15 min on ice. Primary 
antibodies were then added at suggested dilutions (appendix C) and incubated for 90 min 
at 4 °C in the dark. Following rinsing, secondary antibodies (appendix C) were added and 
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incubated for 60 min at 4 °C in the dark. The cells were then washed and suspended in 
wash buffer and stored at 4 °C in the dark until analyzed.  
Apoptosis assay was performed as suggested by manufacturer’s instruction with 
1X binding buffer, 5 µL of Annexin V-PE (BD Bioscience), and 5 µL of 7-Amino-
actinomycin D (7-AAD, Life Technologies).  
For cell cycle analysis, single cells were gently vortexed as ice-cold 100% ethanol 
was added to make a final 70% ethanol solution. The cells were then incubated for 2 hrs at 
4 °C in the dark. Ethanol was then removed, and the cells were resuspended in PBS 
containing 20 μg/mL propidium iodide (Life Technologies) and 10 μg/mL RNase (Sigma) 
and incubated for 30 min at 37 °C. Flow cytometric analysis was performed with Lab 
Quanta SC at the UCR Stem Cell Core or BD FACSAria at the UCR Institute for 
Integrative Genome Biology. Data analysis was done using FlowJo 8.7.  
Immunocytochemistry of sectioned aggregates 
Cell aggregates from suspension culture were fixed with 4% paraformaldehyde 
overnight at 4 °C, then treated with PBS-sucrose solution before embedded in an optimal 
cutting temperature (O.C.T.) compound (Sakura Finetek) and frozen at -80 °C. Samples 
were sectioned into 10 µm slices using the Microm HM500 OMV Motorized Cryostat at 
the Institute for Integrative Genome Biology at UC Riverside, then permeabilized with 
0.2% Triton-X (Sigma) and blocked with blocking buffer (5% normal serum and 5% FBS 
in PBS) supplemented with 0.1% Triton X. Primary antibodies were added at the 
recommended dilution and incubated for overnight at 4 °C. Samples were then washed 
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with immunocytochemistry (ICC) wash buffer (1% BSA and 5% normal serum) and 
incubated with an appropriate secondary antibody for 1 hr at room temperature or overnight 
at 4 °C. After excess antibodies are removed with additional washes, samples were then 
mounted using Vectashield mounting medium with DAPI (Vector Laboratories) and 
incubated in the dark for 30 min at room temperature or overnight at 4 °C. Images were 
taken with the Nikon Eclipse Ti at the UCR Stem Cell Core. 
Quantitative Real-Time PCR (qPCR) 
Total RNA of cells was extracted using the Qiagen RNA isolation kit (Qiagen 
RNeasy kit) following the manufacturer’s instructions. Purified RNA was then used to 
synthesize complementary DNA (cDNA) with the iScript cDNA Synthesis Kit (BioRad) 
following the manufacturer’s instructions. Diluted cDNA and specific primers were then 
added with the Taqman Mastermix Fastmix (Quanta PerfeCTa FastMix) for qPCR. The 
relative expression of each targeted gene was calculated by the comparative ∆∆Ct method 
normalized by the level of internal housekeeping gene glyceraldehyde-3 phosphate 
dehydrogenase (GAPDH) and compared to undifferentiated hPSCs from monolayer 
culture controls [19]. The primer sequences used for qPCR are listed in appendix C. 
Protein preparation, SDS-PAGE, and Western blot analysis  
In preparation for protein collection, cells were pre-treated with sodium 
orthovanadate (tyrosine phosphatase inhibitor, 1 mM) for 30 minutes and washed with 1X 
PBS prior to lysis. To obtain whole cell protein lysates, cells were overlaid with 
radioimmunoprecipitation assay buffer (10 mM Tris pH 7.2, 10 mM sodium chloride, 0.1% 
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sodium dodecyl sulfate, 1% Triton X-100, and 1% sodium deoxycholate) supplemented 
with 10 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl 
fluoride, 1x protease inhibitor cocktail (Sigma-Aldrich) and 1x phosphatase inhibitor 
cocktail (Thermo-Fisher). Protein concentrations were measured with the DC protein assay 
kit (BioRad) and 30 μg of protein in 1x Laemmli loading buffer with bromophenol blue 
dye were analyzed using sodium dodecyl sulfate polyacrylamide gel electrophoresis. Gels 
were run at 160V for 3 hours. Proteins were transferred to a polyvinylidene fluoride 
membrane (Roche) overnight at 4°C, 30V. After overnight blocking at 4˚C in 5% 
milk/PBS, membranes were incubated with the corresponding primary antibodies 
(appendix C). They were washed in 1x PBS and then incubated with the appropriate HRP-
conjugated secondary antibody for 2 hours at 25˚C. Antibody binding was detected using 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific).  
Statistical analysis 
Data points are presented with a mean value ± standard deviation and were 
examined with a minimum of triplicate samples. Image analyses were also conducted on 
triplicate samples per condition. GraphPad InStat 3 software was used to perform analysis 
of variance (ANOVA) to determine statistical significance between experimental 
conditions. 
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Results 
Impact of different agitation rates for the propagation of hPSCs 
hPSCs are sensitive to a wide range of physical cues [20-23]. In stirred suspension 
systems, such a physical cue is fluidic force due to stirred agitation. Therefore, we assessed 
the impact of varied agitation rates on growth, survival, and maintenance of hPSCs [15, 
24]. Our strategy is outlined in Figure 4.1A, in which five agitation conditions (0 (static), 
40, 60, 80, and 100 rpm) were simultaneously tested on H9s and RIV9-iPSC cell lines. 
Throughout the culture period, we assessed outputs as daily fold increase in cell number 
and found that moderate agitation (60 rpm) resulted in the highest fold increase after 7 days 
of culture (41 and 30 fold increase for H9 and RIV9-iPSC, respectively) (Figure 4.1B). The 
growth curve demonstrates that the cell yields for static suspension, and low agitation (40 
rpm) are far inferior to those for moderate (60 rpm) and high agitation (80-100 rpm) for 
both cell lines (Figure 4.1B). The growth curve also suggests that moderate agitation is the 
optimal condition for these cases, and it is likely that excessive agitation attenuates viability 
and growth. Measuring viability based on the population of cells undergoing apoptosis 
addresses how varying agitation can impact the survival of hPSCs in suspension. By using 
an early apoptosis marker, Annexin V (AV), in conjunction with cell death marker 7-AAD, 
we categorized apoptosis into three stages: early (AV+/7-AAD¯), intermediate (AV+/7-
AAD+), and late (AV¯/7-AAD+). Higher agitation rates were found to compromise the 
survival of the cells as evidenced by the increase in overall apoptotic cells (Figure 4.1C). 
Interestingly, although viability percentages in static and low agitation differ slightly from 
that in moderate agitation, the resulting low cell yield produced under these conditions 
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(Figure 4.1B) suggest that the self-renewal capacity of the cells is beginning to decline due 
to a loss in pluripotency. 
Flow cytometry analyses showed that for both cell lines, over 90% of the cell 
population in 60, 80, and 100 rpm expressed pluripotent markers OCT4, TRA-1-60, and 
SSEA-4 (Figure 4.2A). On the other hand, the cells in static and 40 rpm expressed lower 
levels of OCT4 (H9: 73.2% and 85%, respectively; RIV9: 85.5% and 73.7%, respectively) 
and TRA-1-60 (H9: 89.4% and 80.3%, respectively; RIV9: 68.7% and 53.7%, 
respectively), and a drop in SSEA4 expression was observed in the RIV9-iPSC line (83.4% 
and 77%, respectively) (Figure 4.2A). Moreover, we carried out qPCR to measure the 
expression of pluripotency genes OCT4, NANOG, and SOX2. Similar to the flow 
cytometry data, in both cell lines, agitation rates at 60, 80 and 100 rpm maintained high 
expression of all three pluripotency genes, whereas static suspension and 40 rpm resulted 
in a down-regulation of OCT4 gene expression (Figure 4.2C). Interestingly, only the RIV9-
iPSC lines experienced a drop in NANOG expression at static and 40 rpm, whereas the H9 
lines maintained high expression of NANOG for such conditions. Nevertheless, the results 
indicate that static suspension and low agitation rates may not be suitable conditions for 
the expansion of hPSCs. In addition to the low cell yield and the drop in pluripotent markers 
suggest that hPSCs under these conditions have begun to differentiate spontaneously.  
To determine if the drop in pluripotent markers is due to differentiation, we 
examined gene expression levels associated with the three early germ layers: SOX17 
(endoderm), GOOSECOID (GSC, mesoderm), and PAX6 (ectoderm) [25-27]. qPCR 
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analysis revealed that the decrease in pluripotency for static and 40 rpm was accompanied 
by an increase in lineage-specific gene expression. In both cell lines, static suspension 
resulted in the highest level of PAX6, while 40 rpm resulted in the highest levels of SOX17 
and GSC (Figure 4.2D). Notably, besides its involvement in undifferentiated hESCs, SOX2 
is also known to be expressed in neuroectoderm cells [28]. As such, the observed up-
regulation of both SOX2 and PAX6 could indicate that the cells in static suspension were 
likely differentiating towards a neuroectoderm lineage. Additionally, the data suggest that 
agitation could influence differentiation towards the mesendoderm lineage, as evidenced 
by higher expression levels of SOX17 and GSC observed in 40 rpm (Figure 4.2D).  
Collectively, these experiments show that fluidic agitation could be used to enhance the 
propagation of undifferentiated hPSCs and could play a role as a potential means of 
controlling stem cell fate.  
Correlation between size of the cell aggregates and the cell yield 
Another striking difference observed in this test was the morphology and the size 
of the cell aggregates at varying agitation rates (Figure 4.3). Given the varied range of 
sizes, we quantitatively measured the aggregate size distribution and found that static and 
40 rpm further separated themselves from moderate and high agitation rates because of the 
large range of aggregate size distribution. Both static and 40 rpm appear to have multiple 
aggregates agglomerating together to form large clusters (≥400 µm) (Figure 4.3i). In static 
suspension, cell aggregate formation is based on the proximity of neighboring cells freely 
floating in the medium. As such, agglomeration occurs in a stochastic manner, resulting in 
a wide size distribution. In the case of 40 rpm, it is possible that the low agitation creates 
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pockets of minimal mixing where cell aggregates may move to and agglomerate into large 
clusters. In contrast to static and 40 rpm, agitation rates at 60, 80 and 100 rpm produced a 
more homogeneous size distribution. There is a clear trend that size distribution gradually 
shifts toward smaller sizes as the agitation rate increases (Figure 4.3ii). Interestingly, 
though large aggregate sizes (≥400 µm) attribute to less than 10% of the aggregate 
population, these large aggregates account for a large percent (20-60%) of the total cell 
population (Figure 4.3iii). Clearly, fluidic mixing caused the observed phenomena, 
including the significant changes in growth rate and aggregate size distribution. However, 
it is not clear if agitation directly impacted the cell growth and consequently the overall 
size, or the flow controlled formation of cell aggregates, which then modulated cell growth.  
The effect of aggregate size on expansion rate 
In an attempt to decouple the impacts of fluidic agitation and the aggregate size on 
the observed cell yield, we investigated how aggregates at prescribed sizes could affect 
growth, viability, and maintenance of pluripotency. A calculated number of single cells 
were seeded in a V-shaped or U-shaped microwell plate on day 0 to obtain cell aggregate 
size of approximately 100, 200, 300, 400, and 500 µm in diameter on day 7 (Figure 4.4A 
& 4.4B). The population growth curve was interpolated based on the aggregate cell density 
and the progression of aggregate size as a function of time (Figure 4.4C). The highest 
growth rate was found when starting with approximately 150 cells to obtain an aggregate 
size of ~300 μm on day 7. This condition had an initial viability of ~70% on day 1, then 
progressed to 85.7% viability and a 35 fold increase in population by day 7 (Figure 4.4C 
& 4.4D). 
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In addition to viability, we wanted to address whether aggregate size could also 
impact hPSC proliferation kinetics. To evaluate the proliferative capacity of the cells, we 
performed cell cycle analysis using propidium iodide and flow cytometry to determine the 
subpopulation of cells that resides in the G0/G1 phase, S phase, or G2/M phase. The cell 
cycle analysis revealed a bell-shaped distribution for the percentage population of cells in 
the G2/M phase, where the 300 μm size aggregates were the most proliferative (29.5%) 
and the 100 μm and 500 μm aggregates were the least proliferative cells (Figure 4.4E). 
Notably, although the 100 μm and 500 μm size aggregates had similar G2/M percentage 
(~18.0%), the G0/G1 and S phase percentages displayed their different proliferation 
kinetics. Furthermore, we observed a clear trend where the subpopulation in the quiescent 
(G0/G1) phase increased and the subpopulation in the replication (S) phase decreased 
proportionally to the aggregate size (Figure 4.4E). This result suggests that the cells in the 
100 μm sized aggregates entered accelerated growth while anything above 300 μm lead 
towards the quiescent state. These differences in the cell cycle progressions correlated with 
the observed cell yield as aggregate size increased (Figure 4.4C & 4.4E).  
However, hPSC regulation of the cell cycle is also known to link to its stemness 
[29]. As such, we examined the influence of aggregate size in the maintenance of 
pluripotency. Results from flow cytometry demonstrated that only the large aggregates 
(around 400 μm and above) exhibited a decrease in pluripotency, as shown by the reduction 
in pluripotency marker OCT4 (Figure 4.5A). Furthermore, qPCR analysis confirmed a drop 
in OCT4 pluripotent gene expression as aggregates grew larger than 300 μm (Figure 4.5B). 
This drop in pluripotency and proliferation rate observed in large aggregates suggest that 
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the cells were beginning to differentiate. Results from qPCR indicate that aggregates 
greater than 300 μm were beginning to differentiate spontaneously since gene expression 
for all three early germ layers were significantly up-regulated (Figure 4.5C) [30]. This 
phenomenon is likely due to diffusion limitation of soluble factors keeping cells located in 
the aggregate center from receiving adequate factors needed for maintenance of 
pluripotency (Figure 4.5D) [31].  
Western blot analysis  
Previous studies have shown that hPSCs can sense and respond to biophysical cues 
in its microenvironment [32]. Biophysical cues are mechanical stimuli that induce 
molecular signaling responses (also known as mechanotransduction), thereby modulating 
regulatory pathways that contribute to the maintenance of pluripotency or initiate early 
lineage-specific differentiation of hPSCs [33]. Mechanotransduction studies have been 
extensively explored for 2D adherent cultures over the past decade. However, 2D and 3D 
methods are disparate culture conditions, and current knowledge of core signaling 
pathways that are affected in 3D cultures is very limited [34]. In an attempted to shed light 
on possible mechano-responsive proteins behind 3D suspension cultures, we performed 
Western blots to identify differences in protein levels in hPSCs cultured under 2D adherent, 
3D static suspension (0 rpm), and 3D dynamic suspension (40 – 100 rpm). 
First, by comparing 2D adherent and 3D static (0 rpm) conditions, both without 
fluidic agitation, the data show the level of phosphorylated ERK was noticeably lower in 
the latter, despite an upregulation of overall ERK levels over the former (Figure 4.6A). A 
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similar trend, although less prominent, was observed or pJNK1/2 and pan-JNK1/2 (Figure 
4.6A). We speculate that these differences arise from the different structural complex and 
signaling proteins involved between the cell-cell and cell-ECM junctions. In 3D 
suspension, hPSCs have no rigid surface to adhere to, thus leading towards cell-cell 
adhesion and forming free-floating aggregate spheroids. In 3D stirred suspension (40 – 100 
rpm), as seen in levels of JNK1/2 phosphorylation, protein levels were further modulated 
as agitation increases. While simple aggregation without stirring (0 rpm) did not seem to 
change β-catenin (CTNNB1) levels, a rpm-dependent CTNNB1 regulation was observed, 
with 40 rpm resulting in the lowest amount of CTNNB1 (Figure 4.6A). Increasing the 
rotation speed had cell line-dependent effects: In RIV9-iPSCs, CTNNB1 increased with 
higher rpm, but always remained below 2D adherent levels, while in H9 cells CTNNB1 
recovered almost to 2D static levels. In addition, there was consistent activation of the 
75kDa CTNNB1 form, which is supposedly the transcriptionally active form at all rpms in 
H9 cells [35], but not the RIV9-hiPSCs.   
We speculate that these differences arise from the different structural complex and 
signaling proteins involved between the cell-cell and cell-ECM junctions. In 3D 
suspension, hPSCs have no rigid surface to adhere to, thus leading towards cell-cell 
adhesion and forming free-floating aggregate spheroids. In 3D dynamic suspension, these 
protein levels are further modulated as agitation increases.  
The most interesting modulation pattern we identified was from levels of AKT and 
pAKT at different agitation rates. As shown in Figure 4.6A, the pan-AKT level increased 
 93 
steadily with the increase in agitation, yet levels of phosphorylated activated AKT 
remained consistently low. This pattern demonstrates that the ratio of pAKT to pan-AKT 
was much lower in dynamic suspension than in static suspension and 2D adherent culture, 
which suggests that fluidic agitation may directly or indirectly inhibit AKT 
phosphorylation.  
Altogether, the western data have two important implications: (1) cells in 3D 
culture conditions have different protein expression levels than those in 2D adherent 
conditions; and (2) fluidic agitation further modulates these protein expression levels of 
hPSCs in suspension. It is important to note that the western blot analyses do not take into 
account differences in protein levels due to aggregate size. However, the wide variation of 
sizes and differences in protein levels between static and 40 rpm suggest that aggregate 
size had little effect on the western data. Furthermore, the trend in protein expression levels 
from 40 to 100 rpm strongly indicates the influence of various agitation rates in modulating 
expression levels regardless of size (Figure 4.6). 
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Discussion 
The advantage of stirred suspension culture is that it enables the efficient expansion 
and large-scale production of undifferentiated hPSCs without the use of costly substrates 
or microcarriers. For instance, our optimal agitation condition resulted in a 30-40 fold 
increase in cell yield after 7 days of culture. Other studies have shown similar or lower fold 
increases with their reported optimal agitation condition (Table 4.1). However, in many of 
these studies, detailed information regarding how other agitation rates in their system 
would affect viability, maintenance of pluripotency, and aggregate size was limited. In this 
study, we present a detailed analysis of various agitation rates and their impacts on the 
expansion of hPSCs in suspension culture. Besides growth, viability, and maintenance of 
hPSCs, we assessed how cell aggregate size played a role in the culture output and 
uncovered molecular changes at the different agitation rates to identify possible 
mechanosensitive signaling proteins at work in dynamic suspension of hPSCs.   
In this study, we used the 125 mL ProCulture glass spinner flask with 50 mL 
working volume and found 60 rpm to be the optimal condition that consistently produced 
the highest cell yield and expansion rate of hPSCs. We observed a pattern with all of the 
tested cell lines that showed a strong relationship between the cell yield and the size of the 
cell aggregates produced at the different agitation rates. Specifically, agitation rates that 
produced cell aggregates greater than 400 µm (static and 40 rpm) yielded a much lower 
fold increase than agitation rates that produced cell aggregates below 400 µm (60-100 
rpm). It is interesting to note that we observed a similar pattern in our preliminary study of 
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different agitation rates (0-120 rpm) using the Corning 125 mL polystyrene disposable 
spinner flask. In this disposable spinner flask, the best agitation rate for the expansion of 
hPSCs was found in the condition that produced the majority of cell aggregates sizes under 
400 µm (100 rpm, Chapter 3). The biggest difference between the ProCulture and the 
disposable polystyrene flasks was that the latter is more primitive in its design while the 
former has added side baffles to enhance aeration and agitation of flask contents. This 
change in design would explain the differences in results between the two systems. 
Nevertheless, data from both systems suggest a common denominator; though higher 
agitation rates attenuate viability, overall, the agitation conditions that produced a more 
homogeneous cell aggregate sizes between 100-300 µm resulted in a higher cell yield and 
improved maintenance of pluripotency compared to conditions that generated larger-sized 
aggregates.  
Optimizing the inoculation density is also considered an important culture 
parameter that can affect expansion rates and cell yield, which we did not explore. 
However, Hunt et al. reported that the effects of varying inoculation densities were 
insignificant for conditions outside the optimal agitation rate [36]. In fact, they found that 
the optimal agitation condition resulted in the greatest growth kinetics regardless of 
inoculation density. Interestingly, they observed that at higher inoculation density, growth 
was initially faster, and speculated that the overall drop in growth rate was due to 
limitations upon reaching a critical aggregate size [36]. We thus investigated this critical 
size using fixed sized aggregates, and our data indicate that this critical size starts around 
400 µm where the population percentage of proliferating cells, as well as pluripotent 
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markers, were reduced (Figure 4.4 & 4.5). Wu et al. demonstrated that if the radii of 
aggregates become greater than the diffusion limitation of essential factors (~150 μm, that 
is ~300 μm in diameter), cells located more than 150 μm from the aggregate surface could 
suffer from the insufficient transport of oxygen and necessary nutrients required for 
maintenance of pluripotency [31]. As such, the reduction in pluripotent markers for 
aggregate size around 400 µm and above was found to be prominent at the center of the 
cell aggregate (Figure 4.5D), and as evidenced by the up-regulation of early germ layer 
gene expressions, this decrease in pluripotency was followed by spontaneous 
differentiation. Additionally, Ungrin et al., through an investigation of suspended cell 
aggregates in microwells, showed similar consequences of large aggregate sizes in both 
maintenance of undifferentiated hPSCs and subsequent direct differentiation toward 
definitive endoderm [37]. Taken together, it appears that an appropriate seeding density 
would aid in the initial aggregate formation to improve viability, but the mixing condition 
controls the aggregate size over the course of culture and the conditions that generate cell 
aggregate sizes greater than 300 µm could impose challenges in expansion and downstream 
process of hPSCs in suspension culture systems. 
Another aspect of this study was to uncover possible mechanosensitive signaling 
proteins at work in our dynamic suspension cultures. Since the discovery of hPSCs, 
understanding of signaling mechanisms has provided practical implications for controlling 
hPSC culture to sustain growth and maintenance of pluripotency, as well as directing 
lineage-specific differentiation [32]. However, signaling mechanisms in suspension 
cultures are often overlooked because little is known about the molecular changes that 
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occur from 2D adherent culture to 3D suspension. Recently, Konze et al. have provided 
some insight into this gap in knowledge by finding that a truncated form of β-catenin is 
present in free-floating hPSC aggregates and describing a model where calpain cleaves β-
catenin to aid in stabilizing pluripotency of hPSCs in suspension [38]. Data presented in 
this study also reveal this truncated form of β-catenin, as well as other changes in protein 
expression levels between 2D adherent culture and 3D static suspension counterpart, albeit 
only in H9 cells.  
More importantly, we suggested regulation of AKT to be a prominent 
mechanosensitive effector in dynamic suspension culture of hPSCs. Interestingly, cross-
talks among AKT and β-catenin pathways have been recently suggested as the master 
regulator in balancing between self-renewal and differentiation in 2D adherent cultures 
[39, 40]. Though it is unclear how the two pathways coordinate together to influence self-
renewal or differentiation in our system, we speculate that pAKT activity may not be 
crucial for self-renewal in dynamic suspension since low expression levels of pAKT was 
found at 60-100 rpm, where pluripotent markers were still apparent. To explain the drop in 
pluripotency at static and 40 rpm, it is plausible that a relative basal level of β-catenin, 
serving as an essential E-cadherin and β-catenin-mediated intercellular adhesion, is more 
critical for self-renewal given that both low and high levels have been shown to promote 
the initial stages of differentiation [41-43]. Nevertheless, the molecular mechanism for this 
remains unclear, and a more thorough investigation is needed to understand interactions 
between fluidic forces and core biochemical signals in 3D culture systems. 
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In summary, we have described that the optimal agitation condition to enhance 
expansion of hPSCs in dynamic suspension requires a balance between producing uniform 
cell aggregates below the critical size and limiting excessive force-related cell death. This 
balance is expected to be an important parameter for scalable production of hPSCs in 3D 
suspension systems. Furthermore, this study suggests fluidic agitation being a critical input 
parameter to potentially alter molecular mechanisms, thereby affecting hPSC fate 
determination in dynamic suspension. This means that fluidic agitation could be a 
considerable physical cue, along with or in place of chemical cues, to facilitate 
differentiation of hPSCs.  
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Table & Figures 
III Table 4.1. Summary of published protocols for the expansion of hPSCs in stirred 
suspension culture system. *Aggregate size was estimated based on the reported number 
of cells per average cluster size. bFGF = basic fibroblast growth factor. CM = conditioned 
medium. FI = fold increase. IL6RIL6 = interleukin-6 receptor fused to interleukin-6. KOSR 
= Knockout-serum replacement. NA = data not available. 
 
  
References 
Cell 
Types 
Stirrer Type  Medium 
Inoculatio
n Density 
(cells/mL
) 
Agitation (rpm)  – 
Culture time point 
Fold Increase (FI) – 
Aggregate Size 
Singh et al. 
2010 
hESCs  
100 ml flask 
(Integra) 
mTeSR1 1 x 105 40 rpm – 7 days 10 FI – 350-500* μm 
Krawetz et al. 
2010 
hESCs 
125 mL flask 
(NDS) 
mTeSR1 1.8 x 104 100 rpm – 6 days 12 FI – NA 
Zweigerdt et 
al. 2011 
hESCs 
and 
hiPSCs 
100 mL flask 
(Integra) 
mTeSR1 1 x 106 40 rpm – 7 days 3 FI – 350-550 μm 
Amit et al. 
2011 
hESCs 
and 
hiPSCs 
100 ml flask 
(Integra) 
DMEM/F12 +  
KOSR, IL6RIL6, 
and bFGF 
1 x 105 60-90 rpm – 6 days 
17.7 FI – NA 
(unpublished data) 
Chen et al. 
2012 
hESCs 
125 mL flask 
(Cimarec 
Biosystem) 
StemPro + 
bFGF 
2.5 x 105 70 rpm – 4 days 4.3 FI – NA 
Abbasalizadeh 
et al. 2012 
hESCs 
and 
hiPSCs 
100 mL flask 
(Integra) 
DMEM/F12-CM 
+ GlutaMAX and 
bFGF 
3 x 105 40 rpm – 8 days 6.5 FI – 190-215 μm 
Olmer et al. 
2012 
hiPSCs 
100 mL flask 
(DasGip Cellferm 
Pro) 
mTeSR1 5 x 105 60 rpm – 7 days 5.5 FI – 100-150 μm 
Wang et al. 
2013 
hiPSCs 
100 ml flask 
(Integra) 
Essential 8 5 x 105 60 rpm – 5 days 3 FI – 150-250 μm 
Hunt et al. 
2014 
hESCs 
125 mL flask 
(NDS) 
mTeSR1 2 x 104 100 rpm – 6 days 12 FI – 150-350 μm 
Current Study 
hESCs 
and 
hiPSCs 
125 mL flask 
(ProCulture) 
mTeSR1 1 x 105 60 rpm – 7 days  40 FI – 100-300 μm 
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Figure 4.1. The impact of different agitation rates for the propagation of hPSCs in dynamic 
suspension. (A) Illustration outlining our culture scheme to assess the influence of varying 
agitation rates on day 0, spinner flasks for the varying agitation rates were seeded with 105 
cells/mL hPSCs each. The daily growth rate was determined, and the cells were 
characterized on day 7. (B) Growth curve of H9-ESC and RIV9-iPSCs over 7 days. (C) 
The viability of H9-ESC and RIV9-iPSCs measured via flow cytometry using Annexin V 
and 7-AAD on day 7. Data points shown as mean ± SD (N=3).  
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Figure 4.2. Influence of agitation rates in maintenance of pluripotency and differentiation 
after 7 days in dynamic suspension. (A) Flow cytometry quantified the subpopulation of 
cells expressing OCT4, TRA-1-60 & SSEA4 pluripotent markers. (B) Sectioned H9 
aggregates from 60 rpm, immunofluorescently stained for OCT4, NANOG, and TRA-1-
60. (C) Gene expression analysis by qPCR for OCT4, NANOG, and SOX2 pluripotent 
genes. (D) qPCR also quantified early germ layer genes for SOX17 (endoderm), 
GOOSECOID (GSC – mesoderm), and PAX6 (ectoderm). Scale bars: 100 µm. Data points 
shown as mean ± SD (N=3). *, p ≤ 0.05; **, p ≤ 0.01. 
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Figure 4.3. Cell aggregate population at varying agitation rates. (A) H9-ESCs and (B) 
RIV9-iPSCs cell aggregate assessment for each agitation rate on day 7. (i) 
Photomicrographs of cell aggregate morphology. (ii) Distribution of aggregate population 
by aggregate size. (iii) Distribution of cell population by aggregate size. Scale bars: 250 
µm. Data points shown as mean ± SD (N=3). 
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Figure 4.4. Controlled size study to assess the influence of aggregate size. (A) Schematic 
diagram showing initial inoculation number of hESC and resulting aggregates on day 7. 
(B) Daily growth of aggregate size. (C) Population growth curves over 7 days. (D) Cell 
viability of prescribed aggregate sizes on day 7. (E) Cell cycle analysis for prescribed 
aggregate sizes on day 7. Scale bars: 200 µm. Data points shown as mean ± SD (N≥5). 
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Figure 4.5. Reduction in the maintenance of pluripotency as aggregate size grows greater 
than 300 µm. (A) Expression of OCT4 pluripotency marker from the prescribed aggregate 
sizes by flow cytometry. (B) Gene expression analysis by qPCR for OCT4, NANOG, and 
SOX2 pluripotent genes. (C) Gene expression analysis for SOX17, GSC, and PAX6 genes. 
(D) Immunostaining of OCT4 pluripotency marker in sectioned aggregate samples. Scale 
bars: 200 µm. Data points shown as mean ± SD (N=3). *, p ≤ 0.05; **, p ≤ 0.01. 
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Figure 4.6. Western blot analysis of selected protein expressions on day 7 samples. (A) 
H9-ESC full western analysis. (B) Truncated form of H9-ESC western to compare with 
(C) RIV9-iPSC.  
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CHAPTER 5: 
CONTROLLING AGITATION TO IMPROVE CARDIAC 
DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS IN 
STIRRED SUSPENSION CULTURE 
Abstract 
Cardiac differentiation of human pluripotent stem cells (hPSCs) has progressed to a point 
where their use in cell therapy appears conceivable. Although hESCs may serve as an 
unlimited source for generating functional cardiomyocytes, current methods of production 
towards clinically relevant numbers of cells are still inefficient. In addition, the 
inconsistency in outcomes from cardiac differentiation protocols presents a limiting step to 
both the research and therapeutic use of hPSCs. In this study, we demonstrate that pausing 
agitation during a critical induction step improved cardiac differentiation efficiency and 
generated over 90% cTnT-positive cells. Our approach was formulated based on our 
previous study where AKT activity was highly regulated by fluidic agitation (Chapter 4). 
We speculated that pausing agitation could be beneficial for AKT activity, and in turn, 
improve cardiac differentiation. Overall, pausing agitation during stage-2 of differentiation 
(WNT inhibition) improved not only differentiation efficiency but also the maturation of 
cardiomyocytes, as indicated by the highly organized sarcomere structure.  
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Introduction 
Despite advances in biotechnology and medicine, cardiovascular disorders are still 
a leading cause of death worldwide. There are different forms of cardiovascular diseases, 
but the common feature in heart failure is a severe loss of cardiomyocytes, the muscle cells 
that make up the contractile heart tissue [1]. The heart is known to be one of the least 
regenerative organs in the body, and a myocardial infarction can damage 25% of the 2-4 
billion cardiomyocytes that reside in the left ventricle [2]. This means that approximately 
1 billion cardiomyocytes need to be replaced to repair the damage. Otherwise, a progressive 
loss would most likely lead to complete heart failure. For this reason, hPSCs have emerged 
as a promising tool for heart regeneration because of their potential to provide an 
inexhaustible supply of human cardiomyocytes [3]. The challenge now is developing a 
scalable production process that could readily provide large quantities of hPSC-derived 
cardiomyocytes at a reasonable cost.  
Progress in cardiac differentiation is at a point where multiple protocols could 
provide a large population of cardiac troponin T (cTnT) positive cells with relative ease 
[4]. For instance, protocols for the scalable production of cardiomyocytes starting from 
embryoid bodies (EBs) could provide over 60% cTnT-positive cells by temporally 
modulating signaling pathways using appropriate soluble factors [5]. However, the efficacy 
of this method may require timing and concentration of growth factors to be individually 
optimized for each hPSC lines, which could be a tedious process for large-scale production. 
On the other hand, the most efficient approach to date only requires temporal modulation 
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of WNT signaling pathway by small molecules to generate over 80% cardiomyocytes [6]. 
This approach, however, lacks scalability because it relies on confluent monolayer cultures 
that may not readily provide large numbers of hPSC-derived cardiomyocytes. Nonetheless, 
the commonality among various established protocols is the importance of timing to 
regulate specific pathways for an effective differentiation process. 
In this study, we aimed to translate this WNT modulation by a small molecules 
protocol to an integrated process for hESC expansion and cardiac differentiation in stirred 
suspension culture. Although similar approaches have been recently reported by other 
groups [7, 8], we present a novel strategy where the agitation condition was leveraged to 
promote cardiac specification and enhance differentiation efficiency. This approach was 
derived from our previous study in which we observed that stirred-agitation reduced AKT 
phosphorylation in suspension cultures of hPSCs. We demonstrate that pausing agitation 
during a critical induction step improved cardiac differentiation efficiency to produce over 
90% cTnT-positive cells. Furthermore, immunofluorescence suggests that this process also 
increases maturation of cardiomyocytes, as evidenced by the highly organized sarcomere 
structure. Overall, this study provides a promising approach for harnessing the 
hydrodynamic conditions for the scalable mass production of cardiomyocytes in stirred 
suspension culture.  
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 Materials and Methods 
Cardiac differentiation in 2D adherent cultures 
 H9 hESC line maintained on geltrex in mTeSR1 were treated with 10 μM Y-27632 
(ROCK inhibitor, ROCKi) for 1 hr at 37 °C prior to enzymatic dissociation to minimize 
cell death caused by single-cell dissociation. The cells were then washed three times with 
1x PBS (Hyclone), treated with 0.25% Trypsin-EDTA solution (Thermo-Fisher) for 10 min 
at 37 °C, gently pipetted to break up clumps, and strained through a 40 μm cell strainer 
(Corning) to obtain single cells. The cells were then diluted (1:10) using 10% fetal bovine 
serum (FBS, Hyclone) in DMEM (Lonza) to inactivate the trypsin, and spun down at 250×g 
for 5 min. Cells were then seeded onto a geltrex-coated cell culture dish at 105 cells/mL in 
mTeSR1 medium supplemented with 10 μM ROCKi (day -4) for 24 hrs. The cells were 
cultured in mTeSR1 during the expansion phase (day -4 to day 0).  
To initiate cardiac differentiation (day 0), cells were treated with 7.5 μM CHIR 
(CHIR99021, GSK3 inhibitor) in RPMI/B27-insulin for 24 hrs, after which the CHIR was 
removed by medium change. At day 3, cells were treated with 5 μM IWP2 (Tocris) for 48 
hrs and were removed during medium change on day 5. Cells were cultured in RPMI/B27-
insulin from day 0 to day 7. Starting day 7, the medium was then changed to RPMI/B27 
(complete) and cultured to day 15, with fresh medium changed every 3 days.  
Expansion and cardiac differentiation in 3D suspension cultures 
 To initiate the expansion phase in 3D suspension, the cells were treated as described 
above, with 10 ROCKi 1 hr before trypsin dissociation. The enzymatically isolated single 
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cells were resuspended in mTeSR1 medium with 10 μM ROCKi and inoculated at a density 
of 105 cells/mL with a total volume of 50 mL per spinner flask (Corning 125 mL ProCulture 
glass spinner flasks) that had been siliconized with Sigmacote (Sigma) following the 
manufacturer’s instruction. ROCKi was removed by complete medium change after 24 hrs. 
The cells grew into and were maintained in mTeSR1 as aggregate spheroids during the 
expansion phase (day -4 to day 0). At day 0, three 1 mL samples were taken from the 
spinner flask to determine the cell concentration. The cells were kept as aggregate 
spheroids for cardiac differentiation, but the starting cell concentration was normalized to 
an even baseline across each spinner flask on day 0. 
 Protocol for cardiac differentiation in 3D suspension was as described in 2D 
adherent culture. For the stage-specific static condition, agitation was paused, and the cells 
were maintained in static suspension under standard culture conditions (37 °C, 5% CO2, 
100% humidity). For the inhibitor study, cells were treated with 10 μM ROCKi (with or 
without 5 μM IWP2) for 48 hrs and were removed during medium change on day 5.  
Daily sampling to determine fold increase  
For each condition, three 1 mL samples were taken from the spinner flask for cell 
counting and replaced with an equal amount of fresh medium. Upon enzymatic digestion, 
the cells were manually counted, and viability was determined by the trypan blue exclusion 
method. The growth curve was generated based on cell count with an adjustment to the lost 
volume due to sampling.  
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Aggregate morphology and quantifying size distribution 
Aggregate samples were taken on specific time points and placed in a 12-mm 
culture dish (BD falcon) for photomicrographs using a Nikon D5100 camera attached to a 
Nikon Eclipse TS100 microscope. For quantifying aggregate size distribution at day 0, 
three samples for each condition were taken and imaged. Image contrast and brightness 
were adjusted by ImageJ, and a custom MATLAB script was used to measure and collect 
the equivalent diameter of each aggregate. 
Flow cytometry 
Cell aggregate samples were trypsinized into single cell as described above. The 
cells were fixed with 4% paraformaldehyde, washed with 1X PBS, and permeabilized with 
0.2% Saponin in wash buffer solution (PBS + 5% FBS) for 15 min on ice. Primary 
antibodies were then added at suggested dilutions (appendix C) and incubated for 90 min 
at 4 °C in the dark. Following rinsing, secondary antibodies (appendix C) were added and 
incubated for 60 min at 4 °C in the dark. The cells were then washed and suspended in 
wash buffer and stored at 4 °C in the dark until analyzed. Flow cytometric analysis was 
performed with ACEA Biosciences NovoCyte flow cytometer at the UCR Stem Cell Core 
or BD FACSAria at the UCR Institute for Integrative Genome Biology. Data analysis was 
done using FlowJo 10. 
Quantitative Real-Time PCR (qPCR) 
Total RNA of cells was extracted using the Qiagen RNA isolation kit (Qiagen 
RNeasy kit) following the manufacturer’s instructions. Purified RNA was then used to 
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synthesize complementary DNA (cDNA) with the iScript cDNA Synthesis Kit (BioRad) 
following the manufacturer’s instructions. Diluted cDNA and specific primers were then 
added with the Taqman Mastermix Fastmix (Quanta PerfeCTa FastMix) for qPCR. The 
relative expression of each targeted gene was calculated by the comparative ∆∆Ct method 
normalized by the level of internal housekeeping gene glyceraldehyde-3 phosphate 
dehydrogenase (GAPDH) and compared to undifferentiated hPSCs from monolayer 
culture controls [29]. The primer sequences used for qPCR are listed in appendix C. 
Immunocytochemistry 
Cell aggregate samples were trypsinized into single cell as described above. The 
cells were resuspended in RPMI20 solution (20% FBS in RPMI) supplemented with 5 μM 
ROCKi and plated onto a 0.1% (wt/vol) gelatin-coated coverslip at a concentration of 105 
cells/mL. The cells were incubated for 2 days without medium change, after which the 
medium in replaced with RPMI/B-27 medium and maintained for additional 2-5 days. 
After the desired time is reached, the cells were washed with 1X PBS and fixed with 4% 
paraformaldehyde for 30 min at room temperature (RT). The cells were then washed with 
1X PBS and permeabilized with 0.1% Triton-X (Sigma) and blocked with blocking buffer 
(5% normal serum and 5% FBS in PBS) supplemented with 0.1% Triton X. Primary 
antibodies were added at the recommended dilution and incubated for 3 hrs at RT. Samples 
were then washed with immunocytochemistry (ICC) wash buffer (1% BSA and 5% normal 
serum) and incubated with an appropriate secondary antibody for 1 hr at RT. Samples were 
then mounted using Vectashield mounting medium with DAPI. Images were taken with 
the Nikon Eclipse Ti at the UCR Stem Cell Core and analysis was done using ImageJ.  
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Results 
Optimization of Cardiomyocyte Differentiation in Stirred Suspension Culture 
For cardiac differentiation, the timing of activated regulatory signals at different 
stages of differentiation is crucial for improving efficiency. For this reason, the most 
efficient protocols require step-wise modulation of key regulatory signals for cardiac 
specification. Therefore, we sought to determine if temporally regulating the agitation 
conditions at different stages of differentiation would improve cardiac differentiation 
efficiency. The principle hypothesis of this study is that agitation could play a critical 
mechanotransduction signaling role to impact the culture outcome. Specifically, the role 
of AKT has been implicated as an important signaling factor in lineage determination and 
cardiac specification following early differentiation [9-13]. Since we observed AKT to be 
heavily regulated by fluidic agitation, it is plausible that pausing agitation would rescue 
AKT activity during a specific stage of differentiation to generate pure hESC-derived 
cardiomyocytes. Our strategy is outlined in Figure 5.1, where a four-step process was 
conducted, in which we test the effects of pausing agitation during Stage-1 (S1, WNT 
activation) or Stage-2 (S2, WNT inactivation) of differentiation. We also added a constant 
static (CS) and constant agitation (CA) condition to compare their performances against 
the paused-agitation conditions. Before initiating cardiac differentiation, the cells were 
first expanded in mTeSR for 4 days to obtain large numbers of hESCs aggregates that 
were directly used for differentiation.  
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Since differentiation efficiency also depends on the quality of the starting material, 
the growth, pluripotency, and aggregate morphology from each condition were examined 
at the end of the expansion phase (day 0). In terms of growth, the three conditions that 
were cultured at 60 rpm during the expansion phase resulted in a 4.5 fold increase, while 
the CS condition only produced a 3 fold increase (Figure 5.2A). This result is in 
accordance with our previous study where we found 60 rpm to be more effective in the 
expansion of hPSCs than static suspension conditions. Also from our previous study, we 
found both that the aggregate size and loss of pluripotency could affect the overall cell 
yield. When we quantitatively measured the aggregate size distribution (Figure 5.2B), the 
3 conditions under 60 rpm produced a more homogeneous size distribution (~100-200 
µm) than the wider size distribution in the CS condition. The lower cell yield and larger-
sized aggregates in the CS condition suggest the quality of hESCs had been compromised. 
However, flow cytometry analysis revealed that maintenance of pluripotency was still 
apparent in every condition (Figure 5.2C). Therefore, the lower cell yield is likely the 
product of a reduced proliferation from the larger-sized aggregates, whereas the baseline 
quality of the cells seemed to be similar across all four conditions.  
The effects of stage-specific intermittent agitation  
 Following expansion, mTeSR growth medium was replaced with RPMI1640/B27 
(minus insulin) basal medium supplemented with 7.5 µM of CHIR for 24 hrs to initiate 
WNT activation for stage-1 of differentiation. Since the CS condition could only produce 
a 3 fold increase during the expansion phase, the starting concentration for all four 
conditions was adjusted to approximately 0.3 x 105 cells/mL to ensure a standard baseline. 
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At this point, we paused agitation for the S1 condition, rendering the cells to be cultured 
under static suspension until day 3. Similarly, following stage-1 of differentiation, the 
cells are then treated with 5 µM of IWP2 for 48 hrs to inhibit the WNT pathway and 
initiate stage-2 of differentiation, at which time the S1 condition was cultured at 60 rpm, 
and the S2 condition was cultured under static conditions up to day 7.  
Interestingly, a reduction in growth and viability was observed in the S1 and S2 
condition when the cells were temporarily cultured under static suspension (data not 
shown). By day 15, it was clear that agitated conditions resulted in a higher cell yield 
compared to static conditions (Figure 5.3A). Specifically, the CA condition produced a 6 
fold increase after 15 days of differentiation, followed by the S1 and S2 condition that 
resulted in a 3.8 and 3.4 fold increase, respectively. The CS condition produced the lowest 
cell yield after 15 days at 1.7 fold increase (Figure 5.3A). This result corroborated our 
observation that static suspension mitigates cell proliferation in the S1 and S2 condition. 
Interestingly, though the CA condition resulted in the highest cell yield, flow cytometry 
analysis revealed that this condition was the least efficient in producing cardiac cells, as 
evidenced by the low expression of α-actinin and cTnT cardiac markers (56.7% and 
60.1%, respectively). The CS condition, on the other hand, performed better than the CA 
condition to produce 73.1% α-actinin and 75.4% cTnT-positive population (Figure 5.2C 
& D). Next to that is the S1 condition which resulted in 85.4% α-actinin and 81.9% cTnT-
positive population. Importantly, the S2 condition was the most efficient of all the group 
in generating over 90% positive for both α-actinin and cTnT markers after 15 days of 
differentiation (Figure 5.2C & D).  
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RT-PCR analysis was then performed to examine gene expression levels during 
the differentiation process. At the start of differentiation (day 0), we observed that all of 
the conditions expressed relatively high levels of OCT4 and NANOG pluripotency genes 
(Figure 5.4A). After stage-1 of differentiation (day 3), both OCT4 and NANOG 
expression levels significantly dropped while gene expression for mesendoderm markers 
SOX17 and T increased (Figure 5.4A & B). Interestingly, the CS condition maintained a 
high OCT4 expression level and a lower NANOG expression level than the S1 or S2 
condition. In contrast, the S1 condition expressed the lowest OCT4 expression level, but 
the S2 condition showed the highest NANOG expression levels after 3 days of 
differentiation. This result had an interesting correlation with the mesendoderm markers 
because the S1 condition resulted in the lowest SOX17, but the highest T expression levels 
when compared to the other conditions (Figure 5.4B). This suggests that the condition to 
which the cells are exposed before differentiation could also affect the induction process, 
as indicated by the differences in gene expression levels among the 3 best conditions. 
After day 3, cardiac genes for MYH6 and MYH7 were up-regulated by day 7. Notably, 
MYH6 expression was highest on day 7 and progressively dropped, whereas MYH7 
showed steady up-regulation to the end-point of our study (Figure 5.4C). Remarkably, 
although both α-actinin and cTnT levels were lower in comparison, we found the CS 
condition to exhibit higher MYH6 and MYH7 expression than the S1 and S2 condition. 
One possible explanation for this result is that the CS condition resulted in a heterogeneous 
mixture of non-cardiac and cardiac cells, as well as their different stage of maturation.  
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Nevertheless, these results indicate that stopping agitation during stage-2 of 
differentiation was beneficial in generating over 90% pure cardiomyocytes. This means 
that the S2 condition was able to produce 0.94 x 106 cardiomyocytes per mL, totaling to 
approximately 47 million cardiomyocytes after 15 days of differentiation.  
Inhibiting the possible effects of agitation on AKT activity via Rho/ROCK pathway 
Since it appears that pausing agitation benefitted AKT activity, and in turn 
enhanced cardiac differentiation, it would be interesting to examine if the regulatory effect 
of agitation is mediated by another mechanosensitive effector, inhibition of which may 
also improve cardiac differentiation. A recent study showed that mechanically stimulated 
induced-pluripotent stem cells (iPSCs) promote activation of the Rho/ROCK pathway, 
and subsequently reduction of AKT phosphorylation [9]. Importantly, when the Rho-
associated kinase ROCK was inhibited by ROCK inhibitor (ROCKi), AKT 
phosphorylation was rescued in human iPSCs under mechanical stimulation. This study 
then suggests that the effects of fluidic agitation could potentially be mediated by 
Rho/ROCK signaling, and the use of ROCKi presents a way to negate this effect on AKT 
activity for cardiac differentiation. Therefore, we utilized ROCKi during stage-2 of 
differentiation (+RI) to determine if its effects would improve cardiac differentiation 
similar to pausing agitation (Figure 5.5). Moreover, another condition was added in which 
the cells were treated with ROCKi and agitation, but minus IWP2 (+RI/-IW) as outlined 
in Figure 5.5. This third condition will assess if the fluidic motion and ROCKi are 
sufficient to promote cardiac differentiation without the chemical cue for WNT inhibition.  
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Similar to our previous study, the characteristics of the pluripotent stem cells were 
first evaluated to determine the quality of the starting material before differentiation. After 
the expansion phase, characteristics of the cells from all three conditions were similar in 
their cell aggregate size distribution, cell yield (~5 fold increase), and maintenance of 
pluripotency as evidenced by the high expression of both SSEA4 and OCT4 pluripotent 
markers (over 95%) (Figure 5.6A-C).  
On day 0, the seeding density was readjusted to 0.35 x 105 cells/mL. By day 3, 
aggregate size grew to ~200 µm, and cell number increased to 5 fold (~1.5 x 106 cells/mL). 
Flow cytometry analysis on day 3 reveals that 95% of the cells were positive for Brachyury 
in all of the conditions, indicating their successful induction to Mesendoderm cells (Figure 
5.6D). From the expansion phase to stage-1 of differentiation (day -4 to day 3), the results 
were as expected since the parameters were the same for all three spinners flasks. 
However, after stage-2 of differentiation (day 7), aggregate morphology and cell yield 
differ between the conditions (Figure 5.7). In particular, cell yield from the S2 condition 
significantly dropped from day 3 to day 7 (5.3 to 4.1 fold increase, respectively), but 
leveled off on day 10 to 15 (~3.4 FI) (Figure 5.7A). This initial drop in cell yield occurred 
when agitation was paused during stage-2 of differentiation. Viability was further 
compromised when agitation was resumed, with the percentage of viable cells dropping 
from 85.4% on day 7 to 75% on day 10 (Figure 5.7B).  Notably, the +RI and the +RI/-
IWP2 conditions sustained approximately similar cell number from day 3 to day 10 with 
a slight dropped on day 15 (ranging from 5.0 to 5.5 fold increase), but viability was 
consistently around 90%.  
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On day 10 and 15, flow cytometry was used to quantify the population of cells 
expressing α-actinin, troponin I (cTnI) and troponin T (cTnT) cardiac markers. In addition, 
we performed the same cardiac differentiation protocol in 2D monolayer culture as a 
comparison measurement for the stirred suspension cultures. Interestingly, flow cytometry 
analysis revealed that in most of the tested conditions, the highest expression for α-actinin 
and/or cTnI was observed on day 10, and later expression decreased on day 15 (Figure 
5.8A & B). For instance, the +RI/-IWP2 was the only condition that observed a slight 
increase in α-actinin expression from 89% on day 10 to 90.9% on day 15 (Figure 5.8A). 
Similarly, the monolayer was the only condition that resulted in an increase in cTnI 
expression from 75.2 % on day 10 to 92.7% on day 15 (Figure 5.8B). This result was 
unexpected because all of the tested conditions displayed an increasing expression for α-
actinin (from day 10 to day 15) in our previous study. However, cTnT more accurately 
reflects the efficacy of the protocol, and analysis for cTnT-positive cells did show this 
increasing trend (Figure 5.8C). Overall, the monolayer and the constant agitation 
condition produced the lowest cTnT-positive cells by day 15 (~79.0%). The highest cTnT-
positive cells were found in the S2 condition at 91.4%. Remarkably, the addition of ROCK 
inhibitor, with or without IWP2, resulted in over 80% cTnT-positive cells (86.4% with 
and 82.1% without IWP2) (Figure 5.8C). This result suggests that the Rho/ROCK 
pathway could play a significant role in lineage determination of hPSCs. However, when 
the cells were stained for cTnT, α-actinin, and MLC2a on day 22, the cells generated from 
constant agitation and +ROCKi (with or without IWP2) displayed structural features that 
suggest such conditions may not be sufficient to enhance cardiomyocyte commitment. In 
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particular, the cardiomyocytes produced under constant agitation and +ROCKi condition 
were small in their morphology and showed irregular subcellular organization and low 
myofibril density, which are the characteristics consistent with fetal and immature hPSC-
derived cardiomyocytes (Figure 5.9). As human cardiomyocytes mature, they increase in 
size with a more elongated morphology due to physiological hypertrophy. In particular, 
adult cardiomyocytes have a rod-shaped morphology and a highly organized sarcomere 
structure, the contractile unit of cardiomyocytes. The cells in the stage-2 static condition 
displayed such mature features with visibly clear striated patterns, indicating a dramatic 
maturation in their morphology (Figure 5.10). Motivated by this initial observation, we 
further examined the structural features of the stage-2 static cells to characterize their stage 
of maturation on day 22.   
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Characterizing the Structural Maturation of hESC-derived Cardiomyocytes 
 In addition to providing a scalable method for mass production of hPSC-derived 
cardiomyocytes, their functional characteristic is an important criterion for translation into 
clinical applications. For this reason, we plated the cells on day 18 and fixed/stained on 
day 22 to evaluate the structural maturation via immunofluorescence. The cells were 
double-stained for cTnT or α-actinin with myosin light chain two atrial isoforms (MLC2a) 
to determine the assembly of myofilament proteins in sarcomeres. In particular, 
overlapping MLC2a with α-actinin marks the A-bands and the Z-disks sarcomere border, 
respectively, to show if the different functional units of the sarcomere are aligned and 
highly organized similarly to that of adult cardiomyocytes [10].  
 Immunocytochemistry (ICC) showed that the S2 cells have a lot of characteristics 
that are typically observed in mature cardiomyocytes. Specifically, the high degree of 
myofilament protein density and the altering pattern of A-bands and Z-disks labeling is in 
accordance with previously published reports on the structural maturation of 
cardiomyocytes [11] (Figure 5.11). Among its morphological features, the cell’s 
perimeter, area, and circularity could be used to distinguish the cardiomyocyte stage of 
maturation. The cardiomyocytes with a more mature phenotype have a larger perimeter 
and area, and a decrease in circularity index compared to the immature phenotypes. But 
one of the biggest indicators of cardiomyocyte maturation could be observed through the 
sarcomere length, which is the distance between two Z-disks of the sarcomeres [12]. Adult 
cardiomyocytes are more elongated and have longer sarcomere length than fetal or 
immature hPSC-derived cardiomyocytes [13]. Specifically, cardiomyocytes in the early-
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stage of maturation have a sarcomere length of ~1.6 µm, in late-stage maturation the 
length grows to ~1.8 µm, and adult cardiomyocytes have a sarcomere length of ~2.2 µm 
[10, 14]. Typically, improving maturation would require longer culture time, in which 
features of late-stage maturation could be observed if the hPSC-derived cardiomyocyte 
was kept for 50-100 days in culture. However, quantitative ICC analysis of the S2 cells 
shows a dramatic increase in maturation was observed after ~20 days in stirred suspension 
culture (Figure 5.10 & 5.11). Based on the sarcomere length, cardiomyocytes from stage-
2 static condition displayed structural characteristics similar to late-stage maturation 
(Figure 5.11A). But the most surprising are those that resulted in a sarcomere length 
similar to adult-like cardiomyocyte phenotypes (~2.2 µm) (Figure 5.11B & C). However, 
further study of their maturation will require electrophysiological characterization to 
determine if the functional performance of the S2 cells are similar to published reports for 
adult cardiomyocytes. Nevertheless, we were captivated to observe such unprecedented 
degree of structural organization within less than 25 days in culture. This result suggests 
that mechanical stimulation through fluidic agitation could not only improve cardiac 
differentiation efficiency but also rapidly enhance its maturation.  
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Discussion 
 Guiding hPSCs’ fate requires a process to finely tune signaling mechanisms that 
either support growth and self-renewal, or direct lineage-specific differentiation. For 
cardiac differentiation, use of two small molecules to modulate the WNT pathway 
sequentially has enabled efficient production of hPSC-derived cardiomyocytes with 
relative ease [6]. Recently, Kempf et al. adapted this method to develop an integrated 
strategy for hPSCs expansion and cardiac differentiation in stirred suspension culture [7]. 
Although the authors were able to generate up to 85% cardiomyocytes, reproducibility was 
an issue as their results varied between batches with its efficiency ranging from 53.9% to 
84.1%, as indicated by cTnT-positive cells [7]. From our previous study, we identified 
regulation of AKT to be a prominent mechanosensitive effector and suggested that such 
signaling mechanisms in dynamic suspension culture of hPSCS should not be overlooked. 
We speculated that regulation of AKT could be a critical signaling mechanism when 
directing hPSCs fate in stirred suspension culture. Although it is still unclear how the 
down-regulation of AKT was beneficial for the expansion of hPSCs, we presume that its 
role could be associated with lineage-specific determination.  
Here, we explored the possibility of harnessing this agitation-induced regulation to 
improve expansion and cardiac differentiation of hPSCs in stirred suspension culture. Our 
first approach was to determine if pausing agitation would increase AKT activity, and in 
turn, improves cardiac differentiation. From this initial study, we found that the WNT 
inhibition process (stage-2 of differentiation – S2 condition) is the critical time point at 
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which AKT activity is likely necessary for cardiac specification. As such, we were able to 
consistently generate over 90% cTnT and α-actinin positive cells by simply allowing the 
cells to be cultured under static suspension during stage-2 of differentiation (day 3 – 7). In 
comparison to pausing agitation during WNT activation (stage-1 of differentiation – S1 
condition), an S2 condition also displayed higher mesendoderm gene (day 3) and cardiac-
specific gene expressions (day 7 – 15) at their respective time point.  
AKT is a protein kinase that is activated by the phosphoinositide 3-kinase (PI3K). 
AKT is well-known for its role in cellular proliferation and protection from apoptosis, but 
compelling evidence now suggests that AKT activity plays a bigger part in cellular function 
and embryonic development [15-17]. Recently, PI3K/AKT activity has been considered to 
be one of the master regulators for self-renewal of hPSCs in 2D adherent cultures, whereas 
the other being the canonical WNT pathway [18, 19]. For lineage-specific differentiation, 
Freund et al. reported that PI3K/AKT activity, via downstream of insulin-like growth 
factor-1 receptor (IGF-1R), mediates the negative effects of insulin for early cell fate 
decisions towards cardiac lineages [10]. In fact, they reported that insulin strongly 
enhanced phosphorylation of AKT, thereby block mesendoderm induction and promote 
neuroectoderm differentiation. However, Klinz et al. found that PI3K/AKT signaling is an 
important process for cardiac specification. Inhibiting this pathway following hESC early 
differentiation would result in a decrease in cardiomyocyte phenotype [11]. This result 
seems to be in accordance with another report where PI3K/AKT signaling was reported to 
be essential in stimulating proliferation of immature hESC-derived cardiomyocyte [12]. 
Together, these findings suggest a biphasic role for AKT signaling in embryonic 
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cardiogenesis; where the initial inhibition of AKT would favor mesendoderm induction 
[10], but activation of AKT following mesendoderm development is necessary for cardiac 
specification [11] and proliferation of  immature cardiomyocyte [12] (Figure 5.12). This 
process is likely the reason that the S2 condition resulted in the highest cTnT-positive cells. 
It is presumed that agitation was beneficial for mesendoderm induction during stage-1 of 
differentiation, and subsequently, a static condition triggered AKT activity to specify the 
S2 cells towards cardiac development during stage-2 of differentiation. This process 
highlights the notion of how mechanosensitive mechanisms, governed by fluidic agitation, 
could be timely leveraged to enhance hPSCs differentiation in stirred suspension culture.  
In our next set of study, similar to pausing agitation, we utilized ROCK inhibitor to 
counteract the antagonistic effects of agitation on AKT phosphorylation. The Rho/ROCK 
pathway is a molecular feedback mechanism also known to be a primary effector of 
mechanical stimulation. Previous reports have indicated that RhoA/ROCK involvement in 
mechanotransduction signaling is attributed to their downstream cascade interactions with 
pathways such as AKT, ERK, p38 MAP kinases, and JNK signaling [23, 24]. A study by 
Teramura et al. demonstrates this interaction where mechanical stimulation of cyclic strain 
to hPSCs resulted in an up-regulation of RhoA/ROCK pathway and subsequent decrease 
of AKT phosphorylation. But when the Rho-associated kinase ROCK was inhibited with 
ROCK inhibitor, phosphorylation of AKT was recovered under mechanical stress [9]. 
Results from this study are similar to what we observed in our previous study, which 
suggested that the RhoA/ROCK pathway mediates the effect of fluidic agitation on AKT 
signaling activity. Therefore, instead of pausing agitation during stage-2 of differentiation, 
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we added the ROCK inhibitor to rescue AKT phosphorylation and found some 
improvement in producing cTnT-positive cells compared to a continuous agitation 
condition. Interestingly, when we tested a similar condition, but without IWP2, we found 
that both cases of ROCKi treatment (with or without IWP2) resulted in over 80% positive 
expression for three different cardiac markers. This result could suggest an important 
mechanism for Rho/ROCK signaling to promote cardiac differentiation. But this data is 
still inconclusive, and we will need to accumulate more careful evidence to elucidate the 
molecular mechanisms in future studies. Nevertheless, our findings demonstrate a 
connection between fluidic agitation and critical signaling pathways, such as AKT, to 
promote uniform differentiation of hPSCs in stirred suspension culture.  
In addition to producing the highest cTnT positive cells, immunofluorescence 
analysis also suggests that the S2 condition could enhance maturation of hESC-derived 
cardiomyocytes. We were intrigued to find a number of these cells to possess elongated 
morphology with clear striations along the long axis of the cells. Within 22 days of 
differentiation, the cells displayed highly organized sarcomere structure with the visible 
distance between each Z-disks that would extend to neighboring myofibrils. Assessment 
of their sarcomere length suggests some expedited maturation that is similar to those 
previously reported for adult human cardiomyocytes. At this point, the mechanism behind 
this phenomenon remains unknown, but we speculate that the transition between static and 
agitation following stage-2 of differentiation could be the start to myofibrillogenesis. 
Interestingly, Fischer et al. show that overexpression of nuclear AKT actually hindered 
lineage commitment of cardiac progenitor cells [13]. As such, it is plausible that the 
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transition from static to agitation attenuated AKT activity, just as the authors found that 
inhibition of AKT kinase significantly improved lineage commitment in their cardiac 
progenitor cells. Nonetheless, it is difficult to validate this speculation since our findings 
are only initial results to demonstrate how signaling mechanism from both mechanical and 
chemical cues could be tailored to enhance hPSCs differentiation in stirred suspension 
culture. Future studies using qPCR and western blot would provide more insight into this 
mechanism from early hPSCs differentiation to cardiomyocyte development and 
maturation.  
 In summary, we presented an interesting study on how fluidic agitation could be 
leveraged to promote cardiac differentiation in stirred suspension culture of hPSCs. 
Although the actual mechanism is still unclear, we provide a proof-of-concept result that 
supports agitation to be a critical parameter in altering molecular mechanism, thereby 
effecting hPSC fate determination in dynamic suspension.  
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Figures 
Figure 5.1. Optimization of hESCs cardiac differentiation in stirred suspension culture. 
Scheme for constant static (CS), stage-1 static (S1), stage-2 static (S2), and constant 
agitation (CA) condition towards cardiomyocyte differentiation via expansion phase, 
Stage-1 differentiation (WNT activation), Stage-2 differentiation (WNT Inhibition), and 
Cardiomyocyte commitment.  
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Figure 5.2. Day 0 analysis before proceeding to cardiac differentiation. (A) Growth curves 
during the expansion phase. (B) Cell aggregate morphology and size distribution. Scale 
bar: 250 µm. (C) pluripotent markers for SSEA4 and OCT4 were quantified by flow 
cytometry.   
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Figure 5.3. Cell yield and differentiation efficiency over the course of the culture. (A) 
Production of cells and (B) photomicrograph of the aggregate morphology after 15 days of 
differentiation. Scale bars: 250 µm. (C) Flow cytometry analysis of day 10 and day 15 
expression of α-actinin and cTnT cardiac markers.   
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Figure 5.4. Marker gene expression over the course of differentiation. Markers for (A) 
pluripotency, (B) mesendoderm and (C) cardiac genes were examined after specific 
process time-point.  
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Figure 5.5. Inhibitor study with ROCK inhibitor to counteract the adverse effect of 
agitation on cardiac differentiation. Scheme for stage-2 static (S2), +ROCKi (+RI), 
+ROCKi and –IWP2 (+RI/-IW), and constant agitation (CA) condition towards 
cardiomyocyte differentiation.   
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Figure 5.6. Baseline quality assessment of the starting material and intermediate product 
before cardiac specification. (A) Aggregate size distribution, (B) SSEA4 pluripotent 
marker, and (C) OCT4 pluripotent marker were examined on day 0. (D) Quality of 
intermediate product was also examined by expression of Brachyury mesendoderm marker 
on day 3.  
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Figure 5.7. Static conditions mitigate overall cell production and viability when agitation 
in resumed. (A) Cell yield over the course of culture. (B) Cell viability.  (C) Aggregate 
morphology over the course of culture. Scale bars: 200 µm.  
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Figure 5.8. Evaluating differentiation efficiency with a monolayer-based method included 
as a comparison. Expression of (A) α-actinin, (B) cTnI and (C) cTnT were examined on 
day 10 and 15 by flow cytometry.  
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Figure 5.9. Structural characterization of cardiomyocytes generated from different stirred 
suspension conditions. Cells from (A) CA and (B) +RI condition were immunostained for 
cTnT, α-actinin, and MLC2a to show expression of myofilament proteins and sarcomeric 
organization. Immunofluorescent staining for +RI/-IWP2 condition not shown due to the 
low fluorescence intensity at the set exposure time. Scale bars: 50 µm.  
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Figure 5.10. Structural characterization of cardiomyocytes generated from Stage-2 static 
condition. Immunostaining for cTnT, α-actinin, and MLC2a shows cells from the S2 
condition to have a large morphology and highly organized sarcomere structure, indicating 
their increase in maturation compared to the other conditions. Scale bars: 50 µm.  
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Figure 5.11. Structural maturation analysis of cardiomyocytes generated from Stage-2 
static condition. Immunolabeling of α-actinin and MLC2a displays the alternating striated 
patterns between the Z-disk and A-bands of the sarcomere structure. Quantitative analysis 
of their morphology and structural organization reveals an unprecedented increase in 
maturation similar to published reports that demonstrate (A) late-stage maturation and (B 
& C) adult cardiomyocyte phenotype in less than 25 days of culture. Scale bars: 25 µm.  
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Figure 5.12. A possible mechanism of how AKT activity governed by fluid agitation was 
used to promote cardiac differentiation of hESC. Mechanism based on our previous data 
and reports of AKT activity in cardiac lineages [9-13, 27, 28].   
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CHAPTER 6: 
CONCLUSION AND FUTURE DIRECTIONS 
In this work, 3D suspension cultures were explored as an alternative culture 
platform for the large-scale production of hPSCs and their derivatives. Although various 
forms of 3D systems are available, a matrix/carrier-free cell aggregate approach was found 
to be the simplest and cost-effective method for the production of hPSCs. Also, from 
chapter 3, utilizing a conventional spinner flask (Corning polystyrene disposable spinner 
flask) was found to be more effective in the expansion of hPSCs than static suspension 
culture. However, stirred-agitation was mainly beneficial if the mixing condition prevents 
large aggregate formation over the course of the culture. As such, when we utilized the 
ProCulture glass spinner flask in chapter 4, production of hPSCs at moderate or high 
agitation rate was far superior to any of the agitation rate in conventional spinner flask 
system. The added side baffles in the ProCulture glass spinner flask enabled the production 
of a more uniformed sized aggregate to which resulted in an increase in cell yield. This 
result demonstrates that aggregate size has more influence on propagation than the 
reduction in viability due to higher agitation rates, albeit higher shear stress could be more 
detrimental downstream of hPSCs processes. Additional studies found that the critical size 
where the proliferation kinetics and even pluripotent markers start to decrease in around 
400 µm and above. Taken together, the agitation conditions that produced a more 
homogeneous cell aggregate within 100-300 µm, where optimal growth and maintenance 
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of pluripotency was sustained, are expected to be an important parameter for scalable 
production of hPSCs in 3D suspension systems. 
Another aspect of this work was to uncover possible mechanotransduction 
signaling proteins at work in dynamic suspension cultures. Since stem cells are capable of 
detecting and processing various physical forces in their microenvironment, it is expected 
that fluidic agitation would have some influence in altering signaling pathways of hPSCs. 
In this study, AKT activity was found to be a prominent mechanosensitive effector that 
was modulated in stirred suspension culture of hPSCs. Upon discovering this 
mechanosensitive effector, protocols for expansion and cardiomyocyte differentiation with 
respect to AKT activity was further optimized to produce over 90% hPSC-derived 
cardiomyocytes consistently. Structural characterization of these cardiomyocytes also 
suggests that the timing of induction cues and fluidic agitation could enhance maturation 
of hESC-derived cardiomyocyte. It is anticipated that our set of studies could provide 
useful implications for other culture designs and lead to more investigations of hPSCs 
mechanobiology in dynamic suspension cultures. 
Future Directions 
This research explores the possibility of harnessing the fluidic microenvironment 
to promote survival, self-renewal and direct differentiation of hPSCs. This research is 
potentially transformative because its success will enable new methods to tightly control 
downstream differentiation process of hPSCs and maximize cell yield while minimizing 
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cost. However, many issues still remains that need to be addressed to further the 
development of stirred suspension culture towards clinical applications.  
Uncovering the shear distributions and flow properties could facilitate the scaling 
up of our suspension system to larger volumes. The spinner flask used in this study has a 
small working volume of 50 ml (125 mL max). If the culture was scaled up, more 
challenges would arise given the uncertainty in the flow regime for differently designed 
systems. This means that the optimal agitation rate for 50 ml may not transfer to the 100 
ml or the 500 ml system. This aspect is crucial because as shown earlier, a slight change in 
agitation condition (e.g. 40 rpm and 60 rpm) could yield a significantly different result. As 
such, detailed characterization of the mixing properties in association with the culture 
outcomes of this study would help elucidate key parameters that must be controlled when 
scaling up.  
As noted earlier, the optimal agitation condition for expansion of hPSCs in stirred 
suspension requires a balance between producing uniform cell aggregates below the critical 
size and limiting excessive force-related cell death. The balance is crucial because the 
transport parameters that control the aggregation dynamics also bestow shear stress that 
the cells experience. The total shear stress includes the local shear given by eddy viscosity, 
which is a function of the flow properties of the vessel. Therefore, to address the issue in 
scaling up, mathematical modeling of the flow properties in 50 mL volume at the optimal 
agitation rate would offer significant insight into determining this balance for larger spinner 
flask systems. In collaboration with Dr. Marko Princevac group in the Department of 
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Mechanical Engineering at UCR, we have begun this phase of development by combining 
the use of Particle Image Velocimetry (PIV) with computational fluid dynamics (CFD) 
modeling through ANSYS CFX program. However, this development is still in an early 
phase with many issues that need to be resolved. In particular, a more accurate analysis 
from the PIV is needed to enact a more accurate turbulence model (e.g., k-ω, k-ε, baseline 
Reynolds stress model) in the CFD. Once these issues are resolved, our effort in this 
direction should provide outstanding contributions to rationalize designs of larger 
bioreactors systems.  
Another issue that must be addressed in the future development is in regards to 
mechanotransduction signaling mechanisms that promotes pluripotency or lineage-specific 
differentiation of hPSCs in 3D stirred suspension cultures. This study has only scratched 
the surface of how fluid agitation impact signaling pathways of hPSCs in suspension, but 
many more studies are needed given that signaling mechanisms may differ greatly between 
3D suspension and 2D cultures. For instance, as mentioned earlier, pAKT is known to be 
essential for self-renewal in 2D methodologies, yet our data indicates that it may not be 
critical in 3D stirred suspension cultures. Reasons for why shear supports pluripotency 
without the need of pAKT should be further investigated. It could be possible that other 
mechanosensitive signaling pathways that mediate the effects of fluidic agitation on AKT 
activity are also responsible for supporting self-renewal.  
Finally, our method of pausing agitation for cardiac differentiation showed 
promising results in improving efficiency and maturation, but more studies are needed to 
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fully understand the efficacy of this process. Such studies include 1) a detailed qPCR 
analysis to provide an extensive comparison of activated genes at different time points in 
each condition, 2) electrophysiology measurements to determine the functional 
characteristics of these hPSC-derived cardiomyocytes and 3) using iPSCs and other ESCs 
lines to address the interline variability of this method. A more crucial need of investigation 
now is understanding the signaling mechanisms behind this process. Clearly, pausing 
agitation at a specific time point is the key factor that allowed signaling pathways to take 
its course for differentiation. Although the overall mechanism is unclear, it is presumed 
that AKT activity governed by fluidic agitation attributed to this result. Ultimately, with 
more evidence of mechanotransduction mechanisms, this method could be further refined 
to enhance cardiomyocyte maturation, and even tailor protocols for differentiation towards 
other lineages including, but not limited to, pancreatic cells and motor neurons (Figures 
6.1).  
Overall, results presented in this work provide strong implications for an innovative 
approach for controlling expansion and differentiation of hPSCs in stirred suspension 
cultures. 
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Figure 
Figure 6.1. Possible mechanism of how shear-induced pathways could assist 
differentiation and lineage specification. Developed based on reported findings in [1-11]. 
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Appendix A 
Power dissipation study in the 125 mL polystyrene disposable spinner flask based 
on Sen et al., 2002. 
We attempt to replicate Sen et al. study so that we could translate the calculation to our 
stirred suspension culture and correlate our observed aggregate size with the power 
dissipated per unit mass. 
Reported parameters for 125 mL Spinner Flask with PPRF-m4 Medium 
Volume Height H 2.674 cm 
Vessel Diameter D or Dt 6.9 cm 
Impeller Diameter d or Di 5.3 cm 
Impeller Width (up to top of magnet) b or W 1.8 cm 
Kinematic Viscosity (@ 37C) ν 8.60E-03 cm2/s 
Dynamic Viscosity (@ 37C) µ 8.50E-01 cP 
Density of Fluid ρ 1.006 g/mL 
Working Volume V 100 mL or cm3 
 
Power Number (Np) is given by:  
 
Where:  
 
 
𝑁𝑝 =
𝐴
𝑅𝑒
+ 𝐵(𝑍)𝑝 
𝑅𝑒 =
(𝑁)(𝑑2)
𝜈
 
𝐴 =  14 + (
𝑏
𝐷
) {670 (
𝑑
𝐷
− 0.6)
2
+ 185} 
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𝐵 = 10^ {1.3 − 4 (
𝑏
𝐷
− 0.5)
2
− 1.14 (
𝑑
𝐷
)} 
 
 
So from the specified parameters: 
 
 
And therefore:  
 
 
 
Altogether,  
Agitation Rate Rev/min (rpm) 60 80 100 120 
 Rev/sec (rps) 1 1.333 1.667 2 
Reynolds number 
 
Re 3.27E+03 4.36E+03 5.44E+03 6.53E+03 
ln(Reynolds Number) ln(Re) 8.091 8.379 8.602 8.785 
Re0.66  208.58 252.19 292.21 329.58 
 
 0.750 0.721 0.698 0.679 
Power Number Np 0.920 0.849 0.796 0.754 
ln(Power Number) ln(Np) -0.083 -0.163 -0.228 -0.283 
 
H/D = 0.388 
b/D = 0.261 
d/D = 0.768 
Coefficient A = 67.20 
Coefficient B = 1.57 
Coefficient p = 1.93 
𝑧 = (
103 + 1.2𝑅𝑒0.66
103 + 3.2𝑅𝑒0.66
) 
𝑝 = 1.1 + 4 (
𝑏
𝐷
) − 2.5 (
𝑑
𝐷
− 0.5)
2
− 7 (
𝑏
𝐷
)
4
 
𝑧 = (
103 + 1.2𝑅𝑒0.66
103 + 3.2𝑅𝑒0.66
) 
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Power Consumed  
 
P (cm2g/s3) 3871.79 8469.30 15500.32 25361.09 
Power 
Dissipated  
per unit 
Mass  
ɛ (cm2/s3) 
 
38.49 84.19 154.08 252.10 
ln(ϵ)  3.628 4.485 5.151 5.696 
These results showed similarities to Sen et al. report. In particular, the plot that 
demonstrates the relationship between Reynolds number and power number were close to 
their report and our result using their specific parameters. In addition, they report a power 
dissipation per unit mass value of 158.9 cm2/s3 for 100 rpm, and our replicated calculation 
resulted in 154.08 cm2/s3 for 100 rpm, further indicating the similarities. As such, we then 
apply our specific parameters to this calculation.  
Parameters for our 125 mL polystyrene disposable spinner flask and mTeSR 
Volume Height H 1.579 cm 
Vessel Diameter D or Dt 6.35 cm 
Impeller Diameter d or Di 4.0 cm 
Impeller Width (up to top of magnet) b or W 1.5 cm 
Kinematic Viscosity (@ 37C) (appendix B) ν 7.40E-03 cm2/s 
Dynamic Viscosity (@ 37C) (appendix B) µ 7.39E-04 Pa·s 
Density of Fluid ρ 0.9985 g/mL 
Working Volume V 50 mL or cm3 
 
𝑃 =  (𝑁𝑃)(𝑁3)(𝑑5)(𝜌) 
ɛ = 
(𝑃)
(𝑉)(𝜌)
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 And  
 
Altogether, 
Agitation Rate Rev/min (rpm) 60 80 100 120 
 Rev/sec (rps) 1 1.333 1.667 2 
Reynolds number 
 
Re 2.16E+03 2.88E+03 3.61E+03 4.33E+03 
ln(Reynolds Number) ln(Re) 7.679 7.967 8.190 8.372 
Re0.66  1.59E+02 1.92E+02 2.23E+02 2.51E+02 
 
 0.789 0.762 0.740 0.722 
Power Number Np 1.286 1.194 1.124 1.067 
ln(Power Number) ln(Np) 0.251 0.178 0.117 0.065 
 
 
  
Coefficient A = 57.842 
Coefficient B = 2.012 
Coefficient p = 1.981 
H/D = 0.2486 
b/D = 0.2362 
d/D = 0.6299 
Power Consumed  
 
P (cm2g/s3) 1314.67 2894.68 5320.59 8730.33 
Power 
Dissipated  
per unit 
Mass  
ɛ (cm2/s3) 
 
26.33 57.98 106.57 174.87 
ln(ϵ)  3.27 4.06 4.67 5.16 
𝑧 = (
103 + 1.2𝑅𝑒0.66
103 + 3.2𝑅𝑒0.66
) 
𝑃 =  (𝑁𝑃)(𝑁3)(𝑑5)(𝜌) 
ɛ = 
(𝑃)
(𝑉)(𝜌)
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Appendix B 
Kinematic viscosity Study 
 
 
Density of MilliQ water at room temperature  
      
  Volume (mL) Mass (g)  Density (g/mL) 
 Trial 1: 10 9.97  0.997 
 Trial 2: 10 9.92  0.992 
 Trial 3: 5 4.96  0.992 
    Average: 0.9937 
    STDev.: 0.00289 
      
      
Kinematic Viscosity of MilliQ water at 37°C Volume: 15 mL 
Viscometer Constant @ 37°C: 0.00392763 mm2/s2, (cSt/s)  
      
 Efflux T: min:sec seconds Kinematic Vis. Viscosity (Pa·s) 
 Trial 1: 3:20 200 0.78553 0.000780551 
 Trial 2: 3:20 200 0.78553 0.000780551 
 Trial 3: 3:21 201 0.78945 0.000784454 
   Average: 0.7868 7.82E-04 
   STDev.: 0.00227 2.25E-06 
      
      
      
Kinematic Viscosity of MilliQ water at 37°C Volume: 7 mL 
Viscometer Constant @ 37°C: 0.00392763 mm2/s2, (cSt/s)  
      
 Efflux T: Temp. (°C) seconds Kinematic Vis. Viscosity (Pa·s) 
 Trial 1: 36.7 179 0.70305 0.000698594 
 Trial 2: 37.1 177 0.69519 0.000690788 
 Trial 3: 37.2 178 0.69912 0.000694691 
 Average: 37.00 178.00 0.6991 6.95E-04 
 STDev.: 0.26 1.00 0.00393 3.90E-06 
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Density of mTeSR at room temperature  
      
  Volume (mL) Mass (g)  Density (g/mL) 
 Trial 1: 10 10.065  1.0065 
 Trial 2: 10 9.99  0.999 
 Trial 3: 5 4.95  0.9900 
    Average: 0.9985 
    STDev.: 0.00826 
      
      
Kinematic Viscosity of mTeSR at 37°C Volume: 15 mL 
Viscometer Constant @ 37°C: 0.00392763 mm2/s2, (cSt/s)  
      
 Efflux T: min:sec seconds Kinematic Vis. Viscosity (Pa·s) 
 Trial 1: 3:33 213 0.83659 0.000835331 
 Trial 2: 3:34 214 0.84051 0.000839252 
 Trial 3: 3:34 214 0.84051 0.000839252 
   Average: 0.8392 8.38E-04 
   STDev.: 0.00227 2.26E-06 
      
      
      
Kinematic Viscosity of mTeSR at 37°C Volume: 7 mL 
Viscometer Constant @ 37°C: 0.00392763 mm2/s2, (cSt/s)  
      
 Efflux T: Temp. (°C) seconds Kinematic Vis. Viscosity (Pa·s) 
 Trial 1: 36.9 189 0.74232 0.000741209 
 Trial 2: 37.5 188 0.73839 0.000737287 
 Trial 3: 37.7 188 0.73839 0.000737287 
 Average: 37.37 188.33 0.7397 7.39E-04 
 STDev.: 0.42 0.58 0.00227 2.26E-06 
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Dynamic viscosity data obtained with help from Professor Tak-Sing Wong’s Group 
at Penn State University. 
Shear rate 
1/s 
Viscosity (Pa.s) 
Milli-Q Water mTeSR DMEM + 10% FBS 
Average Stand. Dev. Average Stand. Dev. Average Stand. Dev. 
0 7.84E-04 6.76E-06 8.31E-04 6.79E-06     
50 7.68E-04 6.6E-05 7.62E-04 9.7E-06 2.11E-03 7.4E-04 
150 7.16E-04 2.5E-05 7.54E-04 9.5E-06 1.37E-03 2.9E-04 
250 7.06E-04 1.7E-05 7.53E-04 9.6E-06 1.16E-03 1.7E-04 
350 6.99E-04 1.4E-05 7.51E-04 9.6E-06 1.05E-03 1.1E-04 
450 6.96E-04 1.4E-05 7.50E-04 8.9E-06 9.90E-04 8.1E-05 
550 6.95E-04 1.5E-05 7.50E-04 8.6E-06 9.47E-04 6.3E-05 
650 6.95E-04 1.6E-05 7.50E-04 8.5E-06 9.18E-04 5.2E-05 
750 6.95E-04 1.7E-05 7.50E-04 8.0E-06 8.97E-04 4.5E-05 
850 6.95E-04 1.8E-05 7.50E-04 8.1E-06 8.80E-04 3.9E-05 
950 6.95E-04 1.8E-05 7.50E-04 9.0E-06 8.67E-04 3.5E-05 
1050 6.95E-04 1.8E-05 7.50E-04 8.8E-06 8.56E-04 3.2E-05 
 
 
 
Shear rate 
1/s 
Viscosity (Pa.s) 
DMEM/F12 + 20% KOSR Osteo Media Osteo-Control 
Average Stand. Dev. Average Stand. Dev. Average Stand. Dev. 
0             
50 2.14E-03 4.9E-04 2.88E-03 5.3E-04 2.67E-03 5.3E-04 
150 1.38E-03 1.9E-04 1.65E-03 1.6E-04 1.57E-03 1.9E-04 
250 1.19E-03 1.2E-04 1.34E-03 9.3E-05 1.29E-03 1.1E-04 
350 1.09E-03 8.5E-05 1.20E-03 6.7E-05 1.15E-03 7.7E-05 
450 1.04E-03 6.6E-05 1.12E-03 5.2E-05 1.08E-03 6.0E-05 
550 9.97E-04 5.3E-05 1.06E-03 4.2E-05 1.03E-03 4.8E-05 
650 9.69E-04 4.3E-05 1.03E-03 3.6E-05 9.92E-04 4.0E-05 
750 9.48E-04 3.6E-05 9.96E-04 3.1E-05 9.65E-04 3.4E-05 
850 9.31E-04 3.0E-05 9.73E-04 2.7E-05 9.46E-04 3.0E-05 
950 9.18E-04 2.6E-05 9.55E-04 2.4E-05 9.29E-04 2.7E-05 
1050 9.07E-04 2.2E-05 9.39E-04 2.1E-05 9.16E-04 2.4E-05 
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Shear rate 1/s 
Shear Stress 
Milli-Q Water mTeSR DMEM + 10% FBS 
Average Stand. Dev. Average Stand. Dev. Average Stand. Dev. 
0 0.00E+00   0.00E+00   0.00E+00   
50 3.84E-02 3.3E-03 3.81E-02 4.8E-04 1.06E-01 3.7E-02 
150 1.07E-01 3.8E-03 1.13E-01 1.4E-03 2.05E-01 4.4E-02 
250 1.76E-01 4.3E-03 1.88E-01 2.4E-03 2.90E-01 4.3E-02 
350 2.45E-01 4.8E-03 2.63E-01 3.3E-03 3.69E-01 4.0E-02 
450 3.13E-01 6.1E-03 3.38E-01 4.0E-03 4.45E-01 3.6E-02 
550 3.82E-01 8.2E-03 4.13E-01 4.7E-03 5.21E-01 3.5E-02 
650 4.52E-01 1.0E-02 4.88E-01 5.5E-03 5.97E-01 3.4E-02 
750 5.21E-01 1.3E-02 5.63E-01 6.0E-03 6.73E-01 3.4E-02 
850 5.91E-01 1.5E-02 6.38E-01 6.9E-03 7.48E-01 3.3E-02 
950 6.61E-01 1.7E-02 7.12E-01 8.6E-03 8.24E-01 3.3E-02 
1050 7.30E-01 1.9E-02 7.87E-01 9.3E-03 8.99E-01 3.3E-02 
 
 
Shear rate 
1/s 
Shear Stress 
DMEM/F12 + 20% KOSR Osteo Media Osteo-Control 
Average Stand. Dev. Average Stand. Dev. Average Stand. Dev. 
0 0.00E+00   0.00E+00   0.00E+00   
50 1.07E-01 2.5E-02 1.44E-01 2.6E-02 1.34E-01 2.7E-02 
150 2.07E-01 2.8E-02 2.47E-01 2.4E-02 2.35E-01 2.8E-02 
250 2.97E-01 2.9E-02 3.35E-01 2.3E-02 3.22E-01 2.8E-02 
350 3.82E-01 3.0E-02 4.20E-01 2.3E-02 4.04E-01 2.7E-02 
450 4.66E-01 3.0E-02 5.03E-01 2.3E-02 4.85E-01 2.7E-02 
550 5.49E-01 2.9E-02 5.86E-01 2.3E-02 5.65E-01 2.6E-02 
650 6.30E-01 2.8E-02 6.67E-01 2.3E-02 6.45E-01 2.6E-02 
750 7.11E-01 2.7E-02 7.47E-01 2.3E-02 7.24E-01 2.6E-02 
850 7.91E-01 2.6E-02 8.27E-01 2.3E-02 8.04E-01 2.5E-02 
950 8.72E-01 2.4E-02 9.07E-01 2.3E-02 8.83E-01 2.5E-02 
1050 9.52E-01 2.3E-02 9.86E-01 2.3E-02 9.62E-01 2.5E-02 
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Appendix C 
Table S1. Antibodies for flow cytometry (FC), immunocytochemistry (ICC) and Western 
blot (WB) 
Antibody Source Dilution 
OCT4 Abcam, ab19857 1:200 (FC), 1:100 (ICC) 
TRA-1-60 Invitrogen, 14880 1:200 (FC), 1:100 (ICC) 
SSEA4 BD Pharmingen, 561565 1:200 (FC) 
NANOG Abcam, ab80892 1:100 (ICC) 
Brachyury R&D Systems AF2085 1:200 (FC) 
α-actinin Sigma-Aldrich, A7811 1:800 (FC), 1:500 (ICC) 
Troponin I (cTnI) Abcam, ab47003 1:100 (FC), 
Troponin T (cTnT) ThermoFisher, MS-295-P 1:200 (FC), 1:100 (ICC) 
Myosin light chain 2a (MLC2a) Synaptic Systems, 311 011 1:100 (ICC) 
ACTIN Abcam, ab8226 1:5000 (WB) 
AKT Cell Signaling Technology, 4691 1:2000 (WB) 
p-AKT S473 Cell Signaling Technology, 9271 1:2000 (WB) 
JNK1/2 Abcam, ab112501 1:2000 (WB) 
p-JNK1/2 T135T137 Abcam, ab131499 1:2000 (WB) 
ERK Cell Signaling, 9102 1:2000 (WB) 
p-ERK T202/Y204 Cell Signaling, 9101 1:2000 (WB) 
CTNNB1 Life Technologies, 138400 1:1000 (WB) 
Donkey Anti-Rabbit IgG Abcam, ab150065 (Alexa Fluor 488)  1:500 (FC & ICC) 
Donkey Anti-Mouse IgG Abcam, ab150109 (Alexa Fluor 488) 
Invitrogen, A-21203 (Alexa Fluor 594) 
1:500 (FC & ICC) 
Goat Anti-Rat IgM Invitrogen, A-21213 (Alexa Fluor 594) 1:500 (FC & ICC) 
Anti-mouse IgG, HRP-linked IgG Cell Signaling Technology, 7076 1:2000 (WB) 
Anti-rabbit IgG, HRP-linked IgG Cell Signaling Technology, 7074 1:2000 (WB) 
Rabbit IgG R&D Systems, AB-105-C 1:200 (FC), 1:100 (ICC) 
Mouse IgG Santa Cruz, sc-2025 1:200 (FC) 
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Table S2. RT-PCR genes 
GENE TaqMan 
GAPDH Hs02758991_g1 
POU5F1 (OCT4) HS00742896_s1 
NANOG Hs04260366_g1 
SOX2 Hs01053049_s1 
SOX17 Hs00751752_s1 
GOOSECOID (GSC) Hs009006630_g1 
PAX6 Hs00240871_m1 
Brachyury (T) Hs00610080_m1 
MYH6 Hs01101425_m1 
MYH7 Hs01110632_m1 
 
